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Abstract 
 
The mitochondrion is a major source of reactive oxygen species (ROS). 
Superoxide (O2•−) is generated under specific bioenergetic conditions at 
several sites within the electron-transport system; most is converted to H2O2 
inside and outside the mitochondrial matrix by superoxide dismutases. H2O2 is 
a major chemical messenger that, in low amounts and with its products, 
physiologically modulates cell function. The redox state and ROS scavengers 
largely control the emission (generation scavenging) of O2•−. Cell ischemia, 
hypoxia, or toxins can result in excess O2•− production when the redox state is 
altered and the ROS scavenger systems are overwhelmed. Too much H2O2 
can combine with Fe2+ complexes to form reactive ferryl species (e.g., 
Fe(IV)=O•). In the presence of nitric oxide (NO•), O2•− forms the reactant 
peroxynitrite (ONOO¯), and ONOOH-induced nitrosylation of proteins, DNA, 
and lipids can modify their structure and function. An initial increase in ROS 
can cause an even greater increase in ROS and allow excess mitochondrial 
Ca2+ entry, both of which are factors that induce cell apoptosis and necrosis. 
Approaches to reduce excess O2•− emission include selectively boosting the 
antioxidant capacity, uncoupling of oxidative phosphorylation to reduce 
generation of O2•− by inducing proton leak, and reversibly inhibiting electron 
transport. Mitochondrial cation channels and exchangers function to maintain 
matrix homeostasis and likely play a role in modulating mitochondrial 
function, in part by regulating O2•− generation. Cell-signaling pathways 
induced physiologically by ROS include effects on thiol groups and disulfide 
linkages to modify post-translationally protein structure to activate/inactivate 
specific kinase/phosphatase pathways. Hypoxia-inducible factors that 
stimulate a cascade of gene transcription may be mediated physiologically by 
ROS. Our knowledge of the role played by ROS and their scavenging systems 
in modulation of cell function and cell death has grown exponentially over the 
past few years, but we are still limited in how to apply this knowledge to 
develop its full therapeutic potential.  
 
I. Introduction 
 
The turn of the century has seen a resurgence of interest in 
mitochondrial generation of reactive oxygen species (ROS), first 
discovered and understood during the late 1960s and early 1970s. The 
renewed interest derives from the newer concept that ROS are not 
always deleterious to cell function and from the use of more sensitive 
and accurate techniques and probes to understand the mechanism of 
ROS generation and scavenging systems. A number of commentaries 
and well-researched reviews have been published since 2000 on the 
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putative mechanisms of ROS production and the complex 
pathophysiologic effects that ROS exert on cell function; many of these 
are referenced throughout this review (8, 27, 31, 48, 55, 59, 66, 72, 
75, 80, 81, 113, 122, 126, 132, 133, 140, 146, 163, 179, 183, 189, 
202, 209, 234, 241, 243, 244, 246, 299, 303, 307, 328). Many of 
these reviews address very specific aspects of mitochondrial 
bioenergetics or deal with nonmitochondrial ROS production or both. 
For this review, we hope to present a comprehensive understanding of 
mitochondrial ROS production sites and their regulation, ROS 
scavenging, and physiologic as well as pathologic effects of ROS, 
particularly as triggers of cell protection. 
 
A. Focus of review 
 
This review focuses primarily on the ROS generated by the 
mitochondrial respiratory complexes, the sites and conditions for ROS 
generation, cell regulation of ROS generation and ROS scavenging, 
cell-damaging effects of ROS vs. physiologic regulation of 
mitochondrial and cell function by ROS, and the emerging role of 
pharmacologic approaches to manipulate generation and scavenging of 
specific ROS. Other potential sources of ROS exist in mitochondria 
(e.g., glycerol-3-phosphate dehydrogenase, acyl-CoA dehydrogenase), 
but their physiological significance remains to be elucidated (8). This 
report concentrates on studies of mitochondria in excitable cells with 
high metabolic rates (i.e., mammalian myocardial and nervous system 
cells). Mitochondrial density is very high in muscle and nerve cells 
because of their higher O2 consumption rate compared with that of 
most other cell types. The number, size, shape, interconnections, and 
location of mitochondria are also different depending on cell types 
(91). Mitochondria also serve different functions within the same cell 
[e.g., in nerve cells (91) and between the interfibrillary and 
subsarcolemmal mitochondria in cardiac cells (213)].  
 
This review summarizes studies on how and why ROS are 
generated by mitochondrial electron-transport complexes in 
physiologically low amounts, perhaps up to 1% or 2% of the total rate 
of O2 consumption (77), to modulate mitochondrial and cell function. A 
number of topics are addressed: How can ROS be generated when the 
level of the electron acceptor O2 is low? What is the source and 
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location of ‘‘good’’ versus ‘‘bad’’ ROS? Which are the physiologically 
relevant ROS, and what are their targets? How are the levels of 
physiologic ROS modulated? How can generation or scavenging of ROS 
be manipulated to support cell function when the cell is stressed? 
Are low O2–induced cell signaling pathways initiated at the 
mitochondrial level, and does an increase or decrease in ROS mediate 
this activity? 
 
This review does not specifically address the significant 
extramatrix and nonmitochondrial sources of ROS [e.g., cytochrome b5 
reductase, perioxisomes, catecholamines, hydroquinones, plasma 
membrane oxidases such as NADPH oxidase, lipoxygenases, 
monoamine oxidases, xanthine/xanthine oxidase, coupled or 
uncoupled nitric oxide synthase, and eicosanoids pathways, among 
others (303)]. Most of these compounds can initially lose an electron 
to form the superoxide anion radical (O2•−) by autooxidation. The 
nonmitochondrial ROS released or formed in the cytosol are buffered 
generally under strong reducing conditions by intracellular thiols, 
particularly glutathione (GSH) and thioredoxin (TRXSH2) by the 
activities of their reductases (303); this topic is addressed only as 
applied to mitochondriaderived ROS. The free radical NO• can have 
profound effects on mitochondrial function (i.e., competing with O2 at 
mitochondrial respiratory complex IV and reacting with O2•− to form 
peroxynitrite). The source of the NO• may be vascular endothelium, 
nerve terminals, or other cytosolic sources. Controversial evidence 
that suggests that NO• may be generated by a mitochondrial NO 
synthase (23, 24, 136, 137), but this review deals primarily with 
respiratory complex–derived O2•− and its products. 
 
B. Ambiguities about ROS 
 
Although much is known of the chemistry of ROS (151), much less is 
known about the specific molecular sites and conditions for electron 
leak and O2•− generation along the electron-transport pathway under 
pathophysiologic conditions (32, 61). Some topics addressed 
subsequently: How and why do singlet electrons escape during 
electron transfer? What are the physiologic pathways for O2•− release? 
How can O2•− be formed during state 3 (ADP-stimulated) respiration 
when the ΔΨm is less polarized because of the influx of protons? How 
can more O2•− be generated when O2 levels decrease? Are isolated 
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mitochondria a proper model for assessing ROS generation? What is 
the relative amount of O2•− generated at sites along the respiratory 
complexes? Does O2•− or other ROS function as an O2 sensor to 
modulate enzyme activity? What distinguishes physiologic from 
pathologic release of O2•−? It is hoped that this review will furnish at 
least satisfactory answers to most of these questions.  
 
II. Overview of Mitochondrial Structure and 
Function 
 
A. Structure 
 
Mitochondria are membrane-enclosed organelles (1- to 10-m 
diameter) that generate most of the cell’s supply of ATP; they also 
have a role in cell signaling and differentiation, Ca2+ buffering, 
apoptosis and cell death, as well as control of the cell cycle and cell 
growth (322). Many of these processes are triggered or mediated by 
Ca2+ or ROS or both. The number of mitochondria in a cell varies 
widely by organism and tissue type. Many cells have only a single 
mitochondrion, whereas others can contain several thousand 
mitochondria (265, 322). Mitochondrial compartments include the 
outer mitochondrial membrane (OMM), the inner membrane space 
(IMS), the inner mitochondrial membrane (IMM), and the cristae and 
matrix (265). The OMM has a protein-to-phospholipid ratio similar to 
that of the plasma membrane (~1:1 by weight) and contains large 
numbers of integral proteins called porins that form channels to allow 
molecules of more than 5,000 Daltons to diffuse freely across the OMM 
(265). Larger proteins also can enter the mitochondrion if a signaling 
sequence at their N-terminus binds to large multi-subunit proteins 
(translocases) that then actively transport them across the OMM. 
Disruption of the OMM permits proteins in the IMS to leak into the 
cytosol, leading to cell death (87). Because the OMM is freely 
permeable to small molecules, the concentrations of small molecules, 
such as ions and sugars, in the IMS is the same as in the cytosol 
(265). However, as large proteins must have a specific signaling 
sequence to be transported across the OMM, the protein composition 
of the IMS is different from the protein composition of the cytosol. One 
protein that is localized to the IMS in this way is cytochrome c (87).  
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The IMM contains proteins with several functions (225, 265): (a) 
redox reactions of oxidative phosphorylation, (b) ATP 
synthase/ATPase, (c) transport proteins that regulate metabolites 
across the matrix, and (d) protein-import machinery. The IMM has a 
3:1 protein-to-phospholipid ratio and is rich in the phospholipid 
cardiolipin, which contains four fatty acids that help to make the IMM 
impermeable (322). Unlike the OMM, the IMM does not contain porins 
and is highly impermeable to all molecules, so that all ions and 
molecules require membrane transporters to enter or exit the matrix.  
 
Mitochondria vary in number and location according to cell type. 
Liver cells have ~1,000–2,000 mitochondria per cell, making up 20% 
of the cell volume (2), and the IMM (+cristae) area is about 5 times 
greater than that of the OMM. In cardiac mitochondria, the cristae area 
is much larger, and mitochondrial volume can reach 30% of cell 
volume. Mitochondria often form a complex 3D branching network 
inside the cell with the cytoskeleton and tight connections to other 
organelles. The association with the cytoskeleton determines 
mitochondrial shape and function (265). 
 
B. Function 
 
The membrane potential across the IMM is formed by the action 
of the respiratory enzymes and the TCA cycle (225, 322). Each 
pyruvate molecule produced by glycolysis is actively transported 
across the IMM and into the matrix, where it is oxidized and combined 
with coenzyme A to form CO2, acetyl-CoA, and NADH (322). The 
acetyl-CoA is the primary substrate to enter the TCA cycle. The 
enzymes of the TCA cycle are located in the mitochondrial matrix, with 
the exception of succinate dehydrogenase, which is bound to the IMM 
as part of complex II. The TCA cycle oxidizes the acetyl-CoA to CO2, 
and, in the process, produces three molecules of NADH and one 
molecule of FADH2, which are a source of electrons for transport along 
the respiratory complexes, and a molecule of GTP (that is readily 
converted to an ATP) (322). The redox energy from NADH and FADH2 
is transferred to O2 in several steps via the electron transport along 
the respiratory complexes. The individual proteins of complexes I to V 
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specifically interact to form defined supramolecular structures, the 
socalled ‘‘respiratory supercomplexes’’ or ‘‘respirasome’’ (114). 
 
Reducing equivalents from the cytoplasm can be imported via 
the malate-aspartate shuttle system of antiporter proteins or fed into 
the electron-transport system (ETS) by using a glycerol phosphate 
shuttle. NADH dehydrogenase, cytochrome c reductase, and 
cytochrome c oxidase perform the transfer, and the incremental 
release of energy is used to pump protons (H+) into the IMS (322). As 
the proton concentration increases in the IMS, a strong 
electrochemical gradient is established across the IMM. The protons 
can return to the matrix through the ATP synthase complex, and their 
potential energy is used to synthesize ATP from ADP and inorganic 
phosphate (Pi) (322). This process, called chemiosmosis, was first 
described by Peter Mitchell (230), who was awarded the 1978 Nobel 
Prize in Chemistry for his work.  
 
III. Mitochondrial Sources and Mechanism of ROS 
Generation 
 
A. Requirement for charged membrane, electron flux, 
and O2 
 
Molecular O2 (dioxygen) has two unpaired electrons with parallel 
spin in different antibonding orbitals. O2•− arises directly from the 
reduction of O2 by transfer of a lone electron to its antibonding orbital 
(151). The electrons are believed to escape from the mitochondrial 
ETS at discrete sites during the transport of electrons (Figs. 1 and 2A) 
from NADH oxidoreductase (complex I) to cytochrome c oxidase 
(complex IV), the ultimate electron acceptor by which O2+4e¯ and 4H+ 
is reduced to 2H2O. Oxygen, necessary for life in aerobic organisms, is 
therefore simply a sink for electrons (66). 
 
The standard reduction potentials of electron carriers in the four 
mitochondrial complexes span the range of redox potentials from 
NADH at complex I (―0.32 V) to O2 at complex IV (+0.82 V) (Fig. 2B). 
The standard reduction potential for the reduction of O2 to O2•− is 
about ―0.16V (307), so many components of the respiratory 
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complexes in the ETS are thermodynamically capable of irreversibly 
transferring an electron to O2. However, the single-electron transfers 
are tightly controlled and quickly coupled with the second electron 
transfer (107, 293, 294). The energy released as electrons are 
transferred along the respiratory chain is conserved into an H+ 
gradient directed outward through the IMM. Ejection of protons 
alkalinizes the matrix to create a transmembrane H+ electrochemical-
potential gradient, the proton motive force (∆H+), comprising the 
membrane potential (ΔΨm, ―150 mV) and the smaller pH-gradient 
potential (∆pHm, ―30 mV) (201). The energy stored in the ∆H+ is 
partially dissipated as H+ reenters the matrix at complex V (ATP 
synthase), which rotates a protein rotor to convert ADP and Pi to ATP. 
This process is reversible. 
 
B. Reactive and nonreactive O2 species and reactants 
 
The generation of ROS from mitochondria was first reported in 
the early 1970s (44, 218). ROS are O2 molecules alone or bound to 
elements C, H, or N in different states of oxidation or reduction (Table 
1) (151). The primordial mitochondrial ROS is the free radical O2•− 
(Fig. 2B), which, as noted earlier, has an added unpaired electron. 
Although O2•− can reduce Fe3+ to Fe2+ and react with other ligands to 
form other radicals, its usual fate is rapid dismutation (Kd=1.6 х 
109M/s) to hydrogen peroxide (H2O2) by superoxide dismutase (SOD) 
in the mitochondrial matrix (MnSOD) and IMS and cytosol (CuZnSOD). 
During the dismutation reaction, the O2•− is first protonated to the 
hydroperoxyl radical (HO2•) (Kd 10 х 107M/s), and two HO2• react (Kd 9 
х 105M/s) to form H2O2 and H2O (151). Thus, the spontaneous 
dismutation rate of HO2• is ~100 times faster than that of O2•− and 
because it is uncharged, HO2•, unlike O2•−, can cross membranes 
(104). With a pKa of 4.8 for the HO2•/O2•− pair, very little O2•− exists as 
the protonated form in the mitochondrial matrix. It follows that 
dismutation of O2•− to H2O2 occurs faster when the matrix pH is lower 
(k=5 х 105M/s at pH 7.0 and 102M/s at pH 11) (151). 
 
Not all ROS are actually free radicals (e.g., H2O2 and 
peroxynitrite, ONOO¯) (Fig. 3). When a free radical reacts with a 
nonradical, the product is another free radical, whereas the interaction 
of two free radicals produces a nonradical (151). For example, ONOO¯ 
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is a nonradical formed from the interaction of NO• and O2•−. ONOO¯ is 
stable at an alkaline pH and fairly nonreactive, but ONOO- - is readily 
protonated (cytosol more than matrix) at cellular pH to ONOOH 
(peroxynitrous acid), which is very cytotoxic, like HO•, and causes 
depletion of –SH groups and other antioxidants, oxidation of lipids, 
DNA strand breakage, as well as nitration of and deamination of DNA 
bases, especially guanine (151). H2O2 is not a free radical and is not so 
strong an oxidant as O2•−, and H2O2, like H2O, diffuses more easily 
through aquaporins than through lipid membranes (37, 38). H2O2 is 
normally maintained at low levels by catalase and glutathione 
peroxidase, among others, which convert H2O2 to H2O and O2. 
 
H2O2 also can participate in the one-electron reaction with 
transition metal ions (e.g., Fe2+ bound to organic molecules) to 
generate various intermediate ferryl species (274, 275), such as 
Fe(IV)=O•, a powerful oxidizing agent that can lead to lipid oxidation 
and DNA damage, as discussed in section VI. The rate constant, k, for 
reactions of Fe2+ is very dependent on the ligand attached to the iron 
(e.g., it is 2 times greater for Fe2+-ADP than for Fe2+-ATP). Ferryl 
species exist only in a complex and are produced at their site-specific 
targets in DNA, proteins, and lipids. Other much slower reactants of 
H2O2 produced are Fe(III)+OH-+HO• (Fenton reaction); this reaction is 
30 times slower than that of ferryl compounds with H2O2, so the 
hydroxyl radical (HO•) is formed in very small amounts and has no 
specific reactivity with biomolecules (144). ONOO¯ is also a stable 
oxidant that, in its protonated form, ONOOH, can produce oxidative 
changes in lipids, proteins, carbohydrates, and nucleic acids. Thus, 
although O2•− and NO• are the initial free radicals, H2O2 rather than 
O2•− is mostly regarded as the relevant biologically active metabolite. 
 
C. Assessing ROS generation 
 
The measurement of the various ROS is dependent on suitable 
techniques to assess levels of ROS. The technique should not directly 
produce ROS or produce artifacts. Preferably the technique should 
directly measure intra- versus extramatrix generation of O2•−. The 
most direct and selective approach to measure specific ROS, notably in 
the matrix, is to use electron paramagnetic resonance (EPR) (16, 129, 
151). EPR is based on absorption of microwave radiation stimulated by 
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an electromagnetic field in molecules such as free radicals and 
transition metal ions with unpaired electrons. Adsorption of microwave 
energy creates two distinct energy levels from the unpaired electrons 
as they transition from a lower state to a higher state. The number of 
unpaired electrons present in a sample is proportional to the amplitude 
of the ESR signal (111). Only stable ROS that accumulate to 
measurable levels can be identified directly at biologic temperatures, 
so either extreme cooling or spin traps, which involve reaction of the 
radical with an adduct that is stable, is used. Examples of EPR signals 
are shown in Fig. 4. 
 
The majority of recent studies on mitochondrial ROS production 
use either the intramatrix fluorescence indicators 2’7’- 
dichlorofluorescein (DCF) or the fluorescent Amplex Red/horseradish 
peroxidase technique to assess H2O2 that is released or converted in 
the buffer (‘‘cytosol’’) surrounding the mitochondria or both. Figure 5 
shows typical recordings of the rate of accumulation (slope) of H2O2 by 
the latter technique. Because of the high catalytic activities of MnSOD 
and CuZnSOD, most O2•− is rapidly converted to H2O2, which is readily 
permeable to the IMM. Therefore, the measurement of intra- versus 
extramatrix-generated O2•− is indirect and incomplete because of its 
rapid dismutation to H2O2 and the sidedness (intra- or extramatrix) of 
O2•− release. 
 
In isolated tissue, other options exist to assess ROS. One is the 
shift in absorbance with reduction of cytochrome c by O2•−; other 
techniques are based on release of photons by chemiluminescence 
probes, such as liminol or lucigenin, on reaction with ROS (111). 
Dihydroethidium (DHE), also known as hydroethidium (HE), is a rather 
specific fluorescent marker for O2•−. O2•− nonenzymatically converts 
DHE to 2-hydroxyethidium (2-OH-E+) or a precursor (331), which 
appears to be rapidly made, is labile, and fluoresces at a slightly 
shorter wavelength (more red) than the heme-peroxidase oxidation 
product ethidium that can intercalate to bound with DNA. Thus, the 2-
OH-E+ signals fluctuate with the O2•− generated in the cell, as now 
shown in many studies by using spectrophotometry (5, 70, 71, 181, 
182, 247, 269, 271, 298, 316, 317). Figure 6 displays a typical 
recording of O2•- assessed by DHE fluorescence in intact hearts. Note 
the dynamic effects of changing temperature in the presence and 
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absence of drugs.  Caution in the use of DHE (and other probes) lies in 
its oxidation to ethidium by cytochrome c in the absence of ROS (33). 
Because the DHE product is altered by drugs that act on the 
mitochondrion (71), it is assumed that mitochondria are the major 
source of O2•− by this method in isolated tissue. A derivative of DHE is 
MitoSOX Red, which has a phosphonium group that selectively targets 
and enters mitochondria in response to the negative membrane 
potential; thus, imaging of the signal in cells indicates a mitochondrial 
source of O2•− (273). 
 
Another method that depends on the interaction of O2•− and NO• 
is the formation of dityrosine from tyrosine by ONOO¯ (29); Fig. 7 
shows an example of the dynamic changes in dityrosine formation in 
intact hearts during a change in temperature and drug treatment. It is 
assumed that the induced shift in wavelength, assessed with 
spectrometry, is an extracellular indicator of ONOO¯ (71, 247, 248). 
Nitration of tyrosine (no color) by ONOO¯ to 3-nitrotyrosine (yellow 
color) is another indicator of reactive nitrogen species usually 
identified in proteins (151). 
 
D. Sites and conditions for mitochondrial ROS 
generation 
 
The specific molecular sites of electron leak are not known with 
certainty, but a great deal of intense investigation has led to sites 
within complexes I and III (Figs. 1 and 2A). Specific mitochondrial 
inhibitors (64, 197) (Table 2) are typically used to (a) force electrons 
to leak outside of the very tight single-electron transfer mechanism 
(e.g., antimycin A) leading to O2•−, or (b) to block electron leak (e.g., 
stigmatellin or rotenone) with glutamate as substrate. For example, 
the increase in ROS induced by antimycin A can be abolished by 
adding either stigmatellin or myxothiazol (256). In the presence of 
glutamate, the inhibitors rotenone, antimycin A, and stigmatellin can 
each increase ROS. However, in the presence of succinate as 
substrate, antimycin A can increase, whereas both stigmatellin and 
rotenone can decrease ROS (255, 256). Thus, the possible pathways 
have been identified primarily with substrates and inhibitors by using 
deductive reasoning, with the understanding that the mechanism of 
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electron leak may be quite different in a more-relevant 
pathophysiologic situation. 
 
E. Complex I (NADH ubiquinone oxidoreductase) 
 
This transmembrane complex (Fig. 1) oxidizes NADH [reduced 
from the transfer of electrons and H+ from tricarboxylic acid (TCA) 
intermediates], uses coenzyme Q10 (ubiquinone, Q) as the electron 
acceptor and is coupled (as are complexes III and IV) with proton 
pumping, thus contributing to the proton motive force, ∆H+. The 
actual mechanism of proton pumping is almost completely unknown, in 
part to the large size of complex I and the difficulty in measuring the 
intermediates in the coupling reaction (201). Complex I is one of two 
major sites of entry for reducing equivalents; the other is complex II, 
succinate dehydrogenase (more precisely known as succinate 
ubiquinone oxidoreductase) (Figs. 1 and 2). Succinate (and – 
glycerophosphate transferred from the cytosol to the matrix by the 
glycerol phosphate shuttle) alone reduces FAD to FADH2, and each 
molecule furnishes two electrons to the respiratory chain, as do 
pyruvate and TCA-cycle intermediates isocitrate, –ketoglutarate, and 
malate, by reducing NAD+ to NADH. 
 
Complex I is probably the major source of mitochondrial 
ROS under most physiologic conditions (335). Exogenous quinones can 
enhance ROS generation from isolated complex I (65). Inhibitors of 
complex I are useful for determining the source of ROS (96, 252). 
Several sites between the Flavin complex and the quinone site have 
been proposed to generate O2•− within complex I (77, 134, 160, 199, 
216, 320). One or more of the Fe-S centers is a likely source (135, 
160, 251), although the ubisemiquinone (QH•) binding site (143, 160, 
200), or the flavin complex (216), per se, could also be sources, as 
depicted in Fig. 8. It has been proposed that complex I has two redox 
active nucleotide-binding sites; the F site is the location for electron 
entry for the NADH oxidation by Q, and coupled translocation of 4 H+ 
for each NADH oxidized; the R site is where electrons exit during the 
succinate-supported NAD+ reduction, which is O2•− generating (321). 
 
When mitochondria oxidize succinate alone (lacking other TCA 
substrates), the energy of the ∆H+ is used to transfer electrons 
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against the redox potentials of the electron carriers from reduced 
coenzyme Q (quinol, QH2) to NAD+, rather than forward to the final 
electron acceptor O2 (Fig. 9). This is called reverse electron transfer. 
Interestingly, a high transmatrix pH gradient appears to contribute 
more than the ΔΨm to O2•− generation with succinate as the substrate 
(Fig. 10) (201). It was suggested that the ∆pH-sensitive O2•− 
generation is mechanistically linked to proton pumping at complex I 
(201). When electrons are transferred backward from complex II (22, 
158, 307), this creates the largest source of O2•− as a percentage of O2 
consumption, although this does not likely occur in vivo. Reverse and 
forward electron flow is believed to contribute to an H2O2-production 
rate of ~400 and 50 pmol/min/mg protein, respectively (256). 
 
Reverse electron transfer requires a large ΔΨm or ∆pH; this 
occurs as electrons are passed to NAD+ until the pool is fully reduced 
to NADH. O2•− generation by this mechanism ceases or decreases if 
the mitochondria are (a) uncoupled by a proton ionophore (e.g., 
CCCP), (b) generating ATP during state 3 respiration, or (c) leaking 
protons into the matrix (matrix acidification or uncoupling proteins). 
Rotenone (Table 2), an irreversible inhibitor of electron transfer from 
the ubiquinone (Q) binding site to complex I, prevents reverse electron 
transfer and ceases O2•− release by this mechanism. This implies that 
O2•− is generated between the rotenone binding site and NAD+ in 
complex I. The physiological importance of succinate only–induced O2•- 
generation by reverse electron transfer is dubious (335). However, 
because succinate is a TCA-cycle intermediate, it along with NADH-
linked substrates likely contributes to O2•− generation during electron 
transfer in vivo, particularly if electron flow is impeded. It was 
reported that succinate concentration–dependent H2O2 generation was 
only slightly reduced in the presence of NADH-linked substrates (335) 
(i.e., succinate-induced H2O2 production occurred under conditions of 
regular downward electron flow in complex I). Because NADH-linked 
oxidation was progressively decreased, but not abolished, by 
increasing succinate concentration, it was proposed that the two 
substrates compete for electron delivery to complex III, with succinate 
‘‘pushing’’ electrons toward and NADH-linked substrates away from 
complex I (335). In this way, succinate concentration may modulate 
the rate of H2O2 release by controlling the QH•/Q ratio. 
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For forward electron transfer, it is postulated that the electrons 
from NADH-linked substrates (e.g., pyruvate) are moved to 
ubiquinone Q via the flavin complex and Fe-S centers to form QH•, and 
in a second step that is linked to a low ∆pH, to form QH2 (200). In the 
absence of rotenone, NAD+- linked substrates can also enhance O2•- 
generation at complex I if the ΔΨm is higher than normal (8); this 
condition of forward electron flow is favored by a high degree of 
reduction of the redox carriers proximal to the complex I proton pump. 
Once in a high redox state, QH• can lose its unpaired electron to O2 as 
all upstream redox centers are fully reduced (200). Moreover, if the 
∆pH is large, QH• is longer lasting, and more O2•− may be formed. It is 
not known whether complex I has a Q cycle (231) like complex III 
(200). O2•− is believed to be released only on the matrix side of the 
IMM at complex I (200, 256, 295). 
 
F. Complex III (co-enzyme Q, bc1 complex, 
ubiquinone/cytochrome c reductase) 
 
This complex (Fig. 11) is believed to contain a Q cycle with an 
inner (Qi) and outer (Qo) pool of ubiquinone (Q) facing the matrix (i) 
and the intermembrane space (o) (42, 43, 97–99, 211, 268, 295, 296, 
307, 308). Evidence for the Q cycle (231) arose when it was reported 
that addition of O2 to anaerobic mitochondria caused a transient 
reduction of cytochrome b rather than an expected oxidation; this 
suggested that at least two different sites for electron transfer existed 
(43). In the subsequent model, QH• is believed to form at both the Qi 
and Qo sites. First, ubiquinone (Q) is fully reduced to QH2 in the inner 
side of the IMM and migrates to the outer side, releasing 2 H+ and 
transferring one electron to cytochrome c1 (Rieske Fe-S protein) to 
form the first QH• and Q (the electron moves on to cytochrome c and 
cytochrome c oxidase (complex IV). The second electron reduces 
cytochrome b so that electrons are moved from Q at the Qo site to the 
Qi site, and Q is reduced to QH2, completing the cycle. Cytochrome c 
and cytochrome c oxidase accept only single electrons in sequence. 
Thus, the complete reduction of Q at the Qi site requires that the Qo 
site must oxidize two QH2 molecules in two successive turnovers. 
This powers the complex III proton pumps, but the second bifurcation 
reaction cannot occur unless the first does (138). Rather than transfer 
an electron to cytochrome c1, the prolonged lifetime of QH• is believed 
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then to allow it to undergo autooxidation by releasing a singlet 
electron to be attacked by O2, forming O2•−. 
 
Myxothiazol is a complex III inhibitor (296) that binds at the Qo 
site of the Q pool to block electron transfer from QH2 at site Qo to Fe-S 
clusters and to cytochrome b2 (Table 2, Fig. 11). Stigmatellin blocks 
transfer of the first electron to the Fe-S center (center P, QH2 oxidation 
site Qo) (96). Antimycin A binds to the Qi site to block electron transfer 
of the second electron to the Qi site. Thus, antimycin A stimulates 
electron leak by inhibiting QH2 formation (center N, Q reduction site) 
so that Q• accumulates at the Qo site, whereas myxothiazol prevents 
formation of Q• at the Qo site (Fig. 11). The finding that antimycin A 
did not affect H2O2 generation when added after myxothiazol indicated 
that myxothiazol stimulates H2O2 generation at a site in the Qo center 
proximal to the site that is inhibited by antimycin A (296). Myxothiazol 
and stigmatellin inhibit the ROS-inducing effect of antimycin A, as 
noted earlier. The QH• radical is fleeting and highly reactive and is not 
readily detected (320). 
 
These studies suggested that O2•− generated at complex III 
would be released into the IMS rather than into the matrix space. 
Evidence for this was found in mitoplasts devoid of the OMM (152). 
This would further suggest that CuZnSOD is responsible for converting 
O2•− to H2O2 in the cytosolic space and that MnSOD would not have 
much importance for protecting the matrix from ROS damage. 
However, the Qi site can also be a site for ROS generation, particularly 
with limited electron transfer into the Qo center of complex III (263). 
Moreover, the MnSOD (matrix SOD) gene knockout is lethal (204, 
214), whereas the CuZnSOD (extramatrix SOD) gene knockout is not, 
although the life span is shortened (118), and oxidative stress is 
elevated by twofold to threefold (235). This indicates the importance 
of high MnSOD activity to convert O2•− to H2O2, which unlike O2•−, can 
easily exit the matrix. The relative amounts and conditions for ROS 
generated by complex III on either side of the IMM that play a 
physiologic role remains to be resolved. This information will be 
important because the balance between antioxidant capacities and 
O2•− generation within and outside the matrix that contribute to overall 
ROS emission is not clear. 
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Most studies indicate that ROS are generated, especially at 
complex I, during state 4, when the redox state and ΔΨm are high 
(Fig. 12), but not during state 3 (ADP phosphorylation). In the 
presence of succinate plus rotenone, O2•− can be generated by forward 
electron transfer via complex III, although at much lower rates than 
for reverse electron transfer with succinate alone, as noted earlier. 
This too requires a high redox state. However, it is possible to observe 
enhanced ROS at complex III with pyruvate/malate or 
succinate/rotenone during state 3 conditions (276) (high respiration, 
ATP synthesis, slightly decreased redox state, and ΔΨm) when O2 
availability is high (Fig. 13) or protein concentration is low (276), or 
when complex I is blocked with rotenone (199) (Fig. 14) and antimycin 
A is given to block the Qi site (308). It is not known how substantial 
ROS are formed pathophysiologically (i.e., hypoxia) if state 3 
conditions are maintained, but small amounts of ROS clearly can 
initiate protective pathways, as discussed in sections VII and VIII. 
 
IV. Pathologic Induction of Mitochondrial ROS Release 
 
Tissue damage during hypoxia and reperfusion after ischemia 
has long been known to be associated with increased levels of various 
ROS (6, 15, 19, 123, 170, 290, 309, 318). Reperfusion after ischemia 
increases markers of ROS. Administration of scavengers of O2•− and 
H2O2, but not of O2•− alone, reduces the extent of injury (70). Isolated 
hearts exhibit a hypothermia-dependent linear increase in both 
O2•− (Figs. 6 and 15) and ONOO¯ (Fig. 7) (71). Although 
nonmitochondrial sources of ROS exist during ischemia [e.g., NAD(P)H 
oxidase (141, 188, 328) and xanthine oxidase (25) in vasculature], 
the majority of ROS are likely derived from the mitochondrial 
respiratory complexes, as shown by the damage to respiratory 
complexes (212, 213, 245) and the effect of mitochondrial inhibitors 
(5, 28, 71, 81–86). The increase in H2O2 generation in mitochondria 
isolated after cardiac ischemia/reperfusion injury was enhanced by 
either rotenone or antimycin A (84); this suggested that both 
complexes I [Q and/or N2 (final) Fe-S center] and III were damaged 
and capable of producing O2•− after ischemia/reperfusion injury. The 
source of O2•− generation during cell hypoxia leans toward complex III, 
in part because a decrease in oxidant stress during hypoxia in 
cytochrome c–null cells mimics the actions of myxothiazol and 
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stigmatellin (145, 146), which in effect prevent electron transfer to 
cytochrome c (Fig. 11). Loss of cytochrome c locks the Rieske 
Fe-S complex and cytochrome c1 in a reduced state and prevents 
oxidation of QH2 by the Fe-S complex to QH• (145, 146). 
 
A. ROS-induced ROS release 
 
In addition to induction of ROS by hypoxia, ischemia, 
hypothermia, and mitochondrial toxins, ROS per se may lead to even 
greater ROS generation in a self-amplifying manner (46, 336). 
Photoexcitation of individual cardiac myocyte mitochondria caused an 
initial slow increase in ROS that culminated in a large burst of ROS 
(Fig. 16) that accompanied an abrupt loss of ΔΨm and opening of the 
mitochondrial permeability transition (MPT) pore (336). This 
phenomenon, called ROS-induced ROS release (336), may be 
associated with Ca2+ overload and may play a role in initiating 
apoptosis, but whether normal stimuli initiate it is not known. It seems 
unlikely that Ca2+ overload can itself induce ROS generation because it 
dissipates ΔΨm and reduces the redox state; but it may hinder the 
ROS scavenger system so that more ROS are liberated (8). During 
early ischemia in isolated hearts, ROS increase along with 
mitochondrial [Ca2+] and the redox state (NADH), as shown in Fig. 17 
(5, 70, 298), and treatment with exogenous intra and extramatrix ROS 
scavengers reduces ROS and mitochondrial [Ca2+] and better 
maintains the redox state (NADH) on reperfusion after ischemia, as 
exemplified in Fig. 18 (70). 
 
Another example is ROS generated by cytosolic NAD(P)H 
oxidase in a loop with ROS generation by mitochondria and then again 
by NAD(P)H oxidase (112). In this recent study, it was found that 
angiotensin II led to mitochondrial dysfunction by activating vascular 
NAD(P)H oxidase via a protein kinase C (PKC)-dependent pathway. 
The O2•− produced by NAD(P)H oxidase appeared to increase 
mitochondrial O2•− generation as well as to decrease NO• 
bioavailability. Moreover, the H2O2 generated by mitochondria was 
proposed to cause a feed-forward activation of more O2•− by further 
activating NAD(P)H oxidase (112). 
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B. ROS–induced Ca2+ loading 
 
Because ischemia and hypoxia are marked in the cell not only 
by ROS release but also by Ca2+ loading, it is not clear whether one 
leads to the other or whether they are completely independent events 
(11). Again, it seems unlikely that increased Ca2+ can induce O2•− 
generation because it can also induce MPT pore opening to abolish 
ΔΨm (59, 297). Ca2+-transport systems are sensitive to redox 
conditions, so damage to Ca2+ import and export systems by ROS is 
more likely to lead to Ca2+ overloading (72). Moreover, ROS-triggered 
MPT pore opening is potentiated by Ca2+ overload (59). Nevertheless, 
it has been postulated that Ca2+ can induce ROS physiologically (59), a 
topic discussed in more detail in section VIII. 
 
An effect of cytochrome c release during MPT pore opening and 
rupture of theOMMis the activation of caspase proteases. The collapse 
of ΔΨm does not occur before these caspases are activated and 
released (267), and cytochrome c may function to shunt any free 
electrons released outside the matrix to complex IV, thus initially 
reducing O2•− generation (8). Activated caspase-3 can disrupt electron 
transfer at complexes I and III (but not at complex IV) to induce O2•− 
generation as a feed-forward pathway, leading to the collapse of ΔΨm 
and initiation of apoptosis (267). This is discussed in more detail in 
section VII. 
 
C. ROS generation during tissue ischemia and hypoxia 
 
During the last decade, it has become increasingly clear that 
ROS are produced not only during reperfusion and reoxygenation after 
ischemia or hypoxia, but also during ischemia (Figs. 17–19) (5, 28, 
70, 181–183, 247, 269, 270, 298, 317) and hypoxia (316). Figures 17 
through 19 show examples of ROS fluctuations during ischemia and 
reperfusion during conditions of ischemia preconditioning, ROS 
scavenging, and hypothermia in isolated hearts. This seemingly 
paradoxic situation of ROS emission during ischemia (145, 146) can be 
explained because cells never truly become anoxic, and so O2 remains 
available to form O2•− radicals (78). The rate of O2•− generation is 
chemically proportional by mass action to the O2 concentration times 
the rate of electron leak (310), but in isolated liver mitochondria, an 
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[O2] >50 M does not alone result in greater O2•− generation, as 
shown in Fig. 20 (161). Mitochondria can respire normally at a very 
low p2; only when p2 decreases to <5–7 torr does respiration begin 
to be limited by the O2 supply (80). The Km for O2 of cytochrome c 
oxidase is <1 M, and mitochondrial function is independent of a p2 
down to <2 torr. If O2 levels are forced to decrease toward zero, 
electron transfer (respiration) through the respiratory complexes 
becomes markedly slowed, and the electron carriers operate at a more 
reduced state. How this occurs is not known, but it has been proposed 
(145, 146) that if the gene for cytochrome c expression were deleted, 
this would prevent cytochrome c1 from giving up its electron at that 
site, and in turn, at the Reiske Fe-S protein site and in QH2 at the Qo 
site, so that the QH• radical, and thus O2•− would not be generated, 
and these sites would remain locked in a reduced state. 
 
During conditions of blocked electron transfer via the respiratory 
complexes and a highly reduced redox state (5, 70, 298), the QH• 
radical may exist too long or be incapable of full reduction to QH2 
because of changes in protein conformation (61, 146, 221), so that 
electrons leak to combine with O2 in a thermodynamically favorable 
reaction. Other possibilities are that a low [O2] at complex IV leads to 
cytochrome c reduction and so limits its capability to scavenge O2•− 
(63, 292), and that access of QH• to O2 is improved at low O2 levels 
(146). 
 
D. Very low p2 and lack of mitochondrial ROS 
generation 
 
Despite the accumulating evidence that ROS are indeed formed 
during ischemia and hypoxia, and mostly from the mitochondrial 
respiratory complexes, a recent direct study refutes that hypoxia 
enhances ROS. In recent, detailed experiments on this apparent 
paradox (161), it was demonstrated in liver mitochondria that between 
20 and 200 M O2 concentration, respiration, H2O2 generation, and 
cytochromes α/α3 redox state were unchanged; the H2O2 production 
rate was lower during state 3 than during state 4. Below 20 M, [O2] 
respiration and H2O2 generation (Fig. 20), both decreased toward zero, 
and the cytochromes α/α3 redox state became more reduced. It was of 
interest, however, that H2O2 generation as a percentage of the 
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respiratory rate increased fourfold (state 4) and sixfold (state 3) from 
20 M to near zero [O2]. It was concluded (161) that (a) hypoxia in 
intact cells may elicit ROS from nonmitochondrial sources, (b) probes 
used are not specific for ROS, (c) cytosolic pathways are required for 
low O2 sensing and ROS generation, (d) inhibition of complex IV by 
NO• is required, (e) a hypoxia-induced decrease in tonal release of 
ROS downregulates signaling pathways involved with ROS, and (f ) the 
fractional increase in ROS generation as a percentage of respiration 
acts as a hypoxia signal. It is, moreover, possible that hypoxia and 
ischemia produce derangements in mitochondrial electron transfer 
because of changes in substrate utilization (e.g., succinate) and redox 
state that lead to generation of O2•− independent of the effect of a 
reduced [O2] to accept electrons at complex IV. 
 
Endogenous NO• modulates respiration by its effect to compete 
reversibly for the O2 binding site on cytochrome c oxidase (complex 
IV) (45, 58, 119). In endothelial cells, blocking the effect of NO• to 
compete for O2 at complex IV with an NOS inhibitor enhanced the rate 
of O2 consumption (respiration) at very low O2 concentrations (89). 
This indicated that NO• inhibition of O2 binding might be responsible 
for the inability of mitochondria to consume O2 readily at low O2 
concentrations. Endothelial cells are a natural source of NO•, and NO• 
may be generated in mitochondria (137, 139), and with O2•−, to 
produce ONOO¯ (and ONOOH), which can modulate cell function, as 
addressed in section III. However, whether the enzyme NO• synthase 
actually resides in the IMM is very controversial (54, 302). 
 
Obviously, much work remains to de done to understand why, 
how, and from where ROS are generated in isolated cell or organ 
systems during hypoxia or ischemia but apparently not in isolated 
hypoxic mitochondria (161) without the use of electron-transport 
inhibitors. It is not known whether the ratio of O2•− generated from 
complex I and from the Qi versus Qo sites changes during hypoxia and 
reoxygenation or during ischemia and reperfusion, and how the 
activities of MnSOD versus CuZnSOD and other cellular antioxidant 
systems modulate the emission (generated minus scavenged) of 
distinct ROS. The specific sites, sidedness, relative amounts of O2•− 
generation, and its products in these complexes remain to be 
elucidated. It is possible that the source of O2•− generation and the 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Antioxidents and Redox Signaling, Vol. 11, No. 6 (June 2009): pg. 1373-1414. DOI. This article is © Mary Ann Liebert, Inc. 
and permission has been granted for this version to appear in e-Publications@Marquette. Mary Ann Liebert, Inc. does 
not grant permission for this article to be further copied/distributed or hosted elsewhere without the express permission 
from Mary Ann Liebert, Inc. 
21 
 
particular kinds and amounts of ROS change during the course of 
ischemia and reperfusion, as suggested by the observed time-
dependent phasic changes in NADH and FAD redox state, 
mitochondrial [Ca2+], and O2•− levels (DHE, ETH) during ischemia 
(examples shown in Figs. 17 through 19) in isolated heart studies (5, 
7, 70, 181, 183, 269, 298). Note, for example, in Fig. 19, that 
MnTBAP, given during brief ischemic pulses before the longer ischemic 
period, reversed the marked decrease in ROS during late ischemia and 
reperfusion induced by ischemia preconditioning (IPC), suggesting that 
O2•− is required to initiate IPC. 
 
V. Antioxidant Defenses Against Pathologic ROS 
Formation 
 
A. SODs, catalase, cytochrome c, GSH, and TRXSH2, 
and other linked redox couples 
 
Cellular antioxidant defenses depend on the reduction potential 
of the electron carriers and the reducing capacity of linked redox 
couples in the matrix (NADH/NAD+ and FADH2/FAD) and cytoplasm 
(10). Severe cell stress can induce ROS formation that exceeds the 
capacity of antioxidant enzymes, so that the net emission of ROS is 
increased. Up to a limit, mitochondrial and cell antioxidant systems are 
capable of neutralizing excess ROS. These include the intra- and 
extramatrix SODs (171, 263), and glutathione (GSH) (253, 279) and 
thioredoxin (TRXSH2) (171) systems (Fig. 21), catalase in the cytosol, 
and cytochrome c in the intermembrane space (discussed in section 
VII). GSH, a tripeptide with the thiol (-SH) group of cysteine as the 
active site, is an abundant source of reducing equivalents; it reduces 
phospholipid hydroperoxides (PHPs) and H2O2, among other peroxides, 
via PHP glutathione peroxidase, an enzyme essential for life (8). GSH 
peroxidase, TRXSH2, and TRXSH2 reductase gene knockouts are also 
embryonically lethal (234). GSH and TRXSH2 are maintained in a 
highly reduced state by their reductases; this allows them to reduce 
effectively H2O2 and lipid peroxides to H2O. The resulting oxidized 
forms, GSSG (glutathione disulfide) and TRXSS (thioredoxin disulfide), 
rely on the NAD(P)H/NAD(P)+ redox state to again become reduced. 
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Thus, efficient mitochondrial bioenergetic function is required for the 
antioxidant activity of these systems. 
 
B. Regulation of genes encoding mitochondrial 
antioxidant systems 
 
The activities of antioxidant redox pairs do not appear to be 
constant. For example, a transcriptional coactivator, (PPAR)- 
coactivator 1- (PGC-1), a major regulator of oxidative metabolism 
and mitochondrial biogenesis, is believed to regulate the mitochondrial 
antioxidant defense system (153, 312). Endothelial cells that 
overexpressed PGC-1 upregulated the activity of oxidative stress–
protective genes (mRNA for MnSOD, Prx3, Prx, TRXSH2, TRXSH2 
reductase, UCP-2, and catalase) and resulted in reduced accumulation 
of ROS, increased ΔΨm, and reduced apoptotic cell death. This work 
(312) indicates that increased mitochondrial demand for energy 
production is met by activation of PGC-1, which also enhances the 
mitochondrial antioxidant defenses. 
 
C. ROS generation versus ROS scavenging 
 
Normally, mitochondria likely serve as a net sink rather than a 
net source of ROS because of these very efficient scavenger systems 
(8), but ROS release can become excessive. During ischemia, O2•− and 
H2O2 levels increase as antioxidant defenses are overwhelmed and 
complex oxygen intermediates are formed (77, 240). One effect of an 
excessive initial release of ROS could be more ROS formation by ROS-
induced ROS release by a mechanism that may involve MPT pore 
opening (336) or by caspase-induced modification of respiratory 
complexes during initiation of apoptosis (267). A high cytosolic 
GSH/GSSG ratio indicates a large reducing capacity to detoxify ROS 
and prevent activation of innermembrane anion channels (IMACs), 
which precedes MPT pore opening (10). The overabundance of ROS 
during Ca2+ overload with a collapsed ΔΨm could reflect more the 
inability of the GSH, Pr-SSG, and TRXSH2 systems to regenerate the 
reduced state (thus less H2O2 removal) than of more ROS to be 
generated (8). 
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Superoxide, as a charged species, is relatively impermeable to 
membranes but can pass through anion (e.g., IMAC) channels (11, 
152). NO• is not ionized and so is much more membrane permeable 
and can compete for O2•− with SOD to produce the nonradical ONOO¯ 
(29), which protonates at a low pH to ONOOH, which is highly reactive 
to tissues. NO• can also react with O2 to form nitrogen dioxide, NO2• 
(brown gas pollutant). The fate of O2•− (depending on NO• availability) 
is typically dismutation to H2O2, which can then be converted to H2O 
by catalase or to site-directed metal radicals [e.g., (Fe=O)2+] in the 
presence of transition metals bound within numerous organic 
molecules. It is the stable and membrane-permeable H2O2 that is the 
most abundant reactant that, in excess, likely leads to damage to cell 
structure and function via these ferryl reactants.  
 
Because ‘‘good’’ ROS are regulators or modulators of normal cell 
function, it is difficult to draw the line on which ROS effects or 
amounts are beneficial and which are deleterious. The so-called 
diverse, non–receptor mediated, ‘‘bad’’ effects of ROS are mentioned 
here, but arbitrarily. It must be emphasized that the net effect of ROS 
is dependent not only on how much was produced, but also more 
important, on how much was not inactivated by antioxidant defenses. 
Thus, the generegulated GSH/GSSG, TRXSH2/TRXSS, and Pr-
SSG/PrSH redox system, as well as other scavengers that play 
important roles in protection against excess ROS-induced injury, are 
the same factors that probably modulate physiologic ROS signaling. 
 
D. MPT pore opening and cytochrome c 
 
Inhibition of MPT pore opening with cyclosporin A could prevent 
loss of the carrier cytochrome c so that an e¯ is normally transferred 
to complex IV from cytochrome c1, and QH• is oxidized to Q rather 
than O2 being reduced to O2•−. As discussed also in section VII, MPT 
pore opening with release of oxidized [Fe(III)] cytochrome c, an O2•− 
scavenger, may reduce ROS emission in the IMS by oxidizing O2•−. 
Inhibiting MPT pore opening may also prevent the loss of enzyme 
scavengers of ROS within the matrix that normally neutralizes ROS in 
the matrix (220). The independence or interrelation of matrix and 
extramatrix ROS release and scavenging and Ca2+ loading with MPT 
pore opening remains unclear. 
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VI. Targets of Excess ROS Emission 
 
A. DNA, proteins, and phospholipids 
 
A sensitive target of excess ROS is mitochondrial DNA (Fig. 22), 
which is subject to an oxidation rate 10- to 20-fold higher than that of 
nuclear DNA (140, 142, 262). This is due in part to the lack of histone 
protection and the proximity to the ETS. For example, ROS 
intermediates can react with desoxyguanosine to form 8-
hydroxydesoxyguanosine (288), which over time interferes with DNA 
duplication and RNA replication (125, 140). Mitochondrial proteins are 
also subject to attack by ROS (88, 121, 157, 257, 318). ROS can 
damage TCA-cycle enzymes, especially aconitase and -ketoglutarate 
dehydrogenase (62, 168, 249, 250, 277). Other damaging effects of 
ROS are on the respiratory complexes, most at complex I and least at 
complex IV (66). Amino acids are also subject to oxidizing attack by 
ROS, and the GSH, TRXSH2 and other redox systems are important not 
only for neutralizing ROS but also for repairing damage due to 
oxidation of proteins by virtue of their thiol groups (189). Protein 
oxidation can lead to unfolding and result in loss of catalytic function 
and degradation (289) [e.g., ROS can damage the Na/K ATPase 
complex (287)]. 
 
Phospholipids are major targets of ROS (48); Transition metal 
radicals like (Fe=O)2+ can initiate lipid peroxidation cascades in 
membranes to generate a complex mixture of short-chain aldehydes 
(Fig. 23), many of which are believed to be toxic. Accumulated ROS 
damage with aging may damage the lipid composition required for 
complex I activity. It was found (319) that liver mitochondria of old 
versus young rats showed a decrease in respiratory rate and reduced 
activity of complex I but not complex III. It was postulated that an 
increase in somatic mtDNA mutations would affect the hydrophobic 
subunits of complex I that are essential for CoQ binding and energy 
conservation, or that age-related defects of complex I, such as direct 
alterations of the protein or lipid environment, particularly cardiolipin, 
which is required for complex I activity, may play a role. 
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B. Role of cardiolipin 
 
Cardiolipin is a phospholipid found only in the IMM that anchors 
the mobile electron carrier cytochrome c to the IMM and optimizes the 
activity of electron-transport complexes, especially complex IV. 
Cardiolipin can be especially damaged by ROS because of these 
important roles (213, 258, 260, 261). Submitochondrial particles that 
exhibit loss of cardiolipin and cytochrome c during ischemia exhibit 
enhanced H2O2 release (83), which suggests their importance in 
protection against ROS. Excess ROS are primarily accountable for 
initiating MPT pore opening with the subsequent swelling, OMM 
rupture, and release of cytochrome c (187) and feedback generation of 
ROS (336). Accumulation of ROS over time is believed to be wholly or 
partially responsible for aging (210), but recently this has been 
questioned for vertebrates (234). 
 
VII. Approaches to Reduce Excess ROS 
 
A. Capacity of mitochondrial and cell reductants 
 
From the foregoing material, it is evident that, to decrease ROS-
mediated cell damage, MPT pore opening (35, 109, 110), and 
apoptosis due to hypoxia, ischemia, or toxins, one could attempt either 
to reduce the ROS generation or to enhance ROS scavenging so that 
overall ROS emission is diminished. Maintaining a large pool of 
reductants (like the GSH system) requires bioenergetically stable 
mitochondria to regenerate the reduced state after detoxifying the 
ROS. Supplying exogenous GSH may be protective but only if sufficient 
NAD(P)H is also available. Other cytosolic and matrix antioxidant 
systems exist, as described in section V. The endogenous mechanism 
of PGC-1–mediated activation of redox cycling systems also was 
discussed in section V. 
 
Chance et al. (77) proposed antioxidant capability must be 
found near sites of ROS production. An antioxidant mechanism, 
located at the site of electron transfer to complex IV and generation of 
O2•− in complex III, is carried out by cytochrome c. Cytochrome c can 
accept or donate an electron, depending on the valence of its heme 
(Fe) state. It was shown that adding exogenous cytochrome c to 
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cytochrome c–depleted mitochondria reduced O2•− levels by sevenfold 
to eightfold (325, 332). In its reduced form (Fe2+), cytochrome c 
normally generates a proton motive force (∆H+) during its oxidation 
by cytochrome c oxidase (complex IV), as one O2 molecule is fully 
reduced to two molecules of H2O by addition of 4e¯ (8, 332). In its 
oxidized form [Fe3+, or Fe(III)], cytochrome c forms O2 and Fe2+ by 
virtue of the reducing ability (e¯ donation) of O2•− with Fe(III), thus 
neutralizing superoxide. Interestingly, Fe2+ cytochrome c, but not 
Fe(III) cytochrome c, can suppress H2O2 levels by giving an e¯ to H2O2 
to form H2O (332, 333). This is called the ‘‘alternative electron-leak 
pathway,’’ (i.e., reduction of preexisting H2O2 to H2O by reduced 
cytochrome c). This mechanism can balance e¯ leak to O2 (forming 
O2•−) with an e¯ leak to H2O2 (forming H2O) and so function to protect 
against too much ROS formation. 
 
Because Fe(III) cytochrome c is a very efficient scavenger of 
O2•− within the matrix, when Fe(III) cytochrome c is released into the 
IMS during MPT pore opening and initiation of apoptotic signaling, it 
could act as an ideal extramatrix antioxidant (292). However, the loss 
of cytochrome c to the IMS may allow matrix O2•− to increase because 
of an absence of cytochrome c (220). 
 
B. Exogenous SODs and catalase 
 
Treatment with superoxide dismutases and catalase is another 
approach. However, effective delivery of these enzymes into the 
cytosol and matrix as a therapy is quite problematic. Overexpression 
of these enzyme systems could be successful in enhancing antioxidant 
defenses, but because ROS also play a significant physiologic role 
(described later), the effects may be deleterious, as indicated by a six- 
to 10-fold overexpression of MnSOD, which caused reduced fertility 
and abnormal development in mice (264), and the lack of any benefit 
to prolonging life span in mice overexpressing CuZnSOD (166). 
However, overexpression of catalase localized to mitochondria 
increased median life span in mice by 5 months (280). We reported 
that administration of the chemical SOD mimetic MnTBAP alone 
actually worsened cardiac function after ischemia in isolated hearts, 
whereas addition of glutathione and catalase with MnTBAP elicited the 
best protection (70); Fig. 18 shows the changes in ROS and 
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mitochondrial Ca2+ during and after ischemia with these treatments. 
Our study suggested that enhanced generation of matrix O2•− during 
ischemia must be coupled with its dismutation to H2O2 and its 
oxidation to H2O to offer the best protection. 
 
C. Proton leak to modulate superoxide generation 
 
Another perhaps more practical approach is to modify 
mitochondrial bioenergetics in a way that leads to reduced capability 
for producing O2•−. As discussed earlier, it may be possible to generate 
O2•− during state 3 or when ΔΨm is less polarized (291, 276, 324), but 
most experimental studies show that even a slight decrease in ΔΨm 
(191, 201, 324) or transmatrix ∆pH (201) results in marked reduction 
or cessation of ROS production. Therefore, temporary partial 
uncoupling of respiration from phosphorylation by inducing an extrinsic 
proton ‘‘leak’’ may be therapeutic. Essentially, this process short-
circuits the gated passage of H+ through complex V to make ATP, so 
that respiration increases at the expense of no gain in phosphorylation 
(mild uncoupling) (47, 49, 60). It takes a greater electron-transfer 
rate to maintain the ΔΨm when an H+ leak is present. Oxidative 
phosphorylation is not wholly efficient, as up to 25% of basal H+ flux 
into the matrix could be outside of complex V, as suggested by the 
heat produced as a fraction of the standard metabolic rate (Fig. 24) 
(55). The net effect of H+ leak is to stimulate respiration (electron 
transfer) and produce heat at the expense of ADP phosphorylation.  
 
H+ leak is maximal when ΔΨm is highly polarized, and little or no 
leak occurs when ATP is being generated. In vitro, state 4 respiration 
occurs only when no substrate ADP exists, ATP is not being consumed, 
or complex V is blocked (oligomycin). Thus, H+ leak may be an 
intrinsic mechanism to attenuate electron leak and O2•− generation 
when the ΔΨm is large. At a high ΔΨm with a greater probability to 
generate O2•−, the maximal capability to have a proton leak would 
tend to decrease ΔΨm and thus O2•−. The mechanism of basal H+ leak 
is unknown but is thought to be protonophoric (i.e., H+ is carried 
across the IMM) (55). H+ leak is assessed indirectly by any increase in 
respiratory rate or decrease in ΔΨm or both during inhibition of 
complex V (Fig. 25). 
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D. Uncoupling proteins 
 
A small class of ‘‘uncoupling’’ proteins, called UCPs 1–4, are 
believed to induce an inward proton ‘‘leak’’ in charged mitochondria 
(49, 55, 176, 300). AMP may also act allosterically on adenine 
nucleotide translocase (aka adenine nucleotide transporter, ANT; or 
ADP, ATP carrier, AAC) to induce an H+ leak (67). Proton leak could 
also be elicited by cycling of protonated/unprotonated nonesterified 
fatty acids (Fig. 24) (55, 132, 175), and by repetitive gating of the 
MPT pore by protons (53, 169). It is feasible that UCPs and AMP could 
play a role in protecting against ischemia and reperfusion injury, 
particularly if they could be activated or stimulated before the insult to 
reduce ΔΨm and before the redox state increases because of inhibited 
electron transfer. Mitochondria isolated from perfused rat hearts 
subject to ischemic preconditioning had a greater H+ leak than did 
ischemia controls (Fig. 25) (238); this H+ leak was completely 
abolished by the UCP inhibitor GDP, or by the ANT inhibitor 
carboxyatractyloside (CAT) (238). ATP also inhibits UCPs (174). 
However, ANT, rather than UCP2, may be most responsible for the 
antioxidant mechanism in heart muscle mitochondria (238). It was 
suggested (238) that the smaller H+ leak induced by ischemic 
preconditioning is mediated by UCP, because the H+ leak in ischemia 
controls was blocked only weakly by GDP, but strongly by CAT, 
whereas the larger leak in ischemia/reperfusion alone is mediated by 
ANT. 
 
E. HNE-induced proton leak 
 
Some lipid peroxidation products, such as 4-hydroxy-trans-2-
noneal (HNE) may induce partial uncoupling of mitochondria through 
UCPs and are thought to initiate protective mechanisms (41, 116). 
HNE can also induce uncoupling of oxidative phosphorylation by 
enhancing H+ leak through other membrane proteins such as ANT if 
ΔΨm is high (14). This H+ leak, although preventable by CAT, did not 
interfere with ANT inhibition (14), so it was suggested that HNE causes 
a conformation change in ANT. Although ROS can activate UCPs (117) 
and ROS and HNE can directly cause a small proton leak (55), whether 
UCPs are activated by either endogenous ROS or HNE has been 
rigorously questioned (75). Because ubiquinone (Q) is not required for 
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activation of UCPs (174), it is unlikely that ROS from complexes I or 
III exert a significant role. Together these studies indicate that mild 
uncoupling by H+ leak reduces ROS formation in state 4 and that UCPs 
can induce a small H+ leak, but evidence that mitochondrial ROS 
activate UCPs and the UCPs mediate protection against ROS-induced 
cell damage is not yet convincing. 
 
It remains unclear how free fatty acids and alkenals like HNE 
activate proteins such as UCPs and ANT (14). One possibility is that a 
protonated fatty acid may cross the IMM into the matrix and 
dissociate, while the fatty acid anion is translocated back out of the 
matrix by the protein. Flip-flopping of the protonated and 
unprotonated forms would cause a net flux of H+ into the matrix; other 
mechanisms are proposed (14). For alkenals (nonfatty acids), it was 
proposed recently that H+ conductance via ANT occurs by formation of 
covalent adducts only at a high ΔΨm, thereby exposing sulfhydryl 
groups and lysine residues to attack by alkenals and causing a 
conformation change in ANT. This was based on the finding that CAT 
blocked H+ leak via ANT if given before but not after HNE, whereas 
blockade of the ANT transport mechanism remained; this that implied 
HNE caused a permanent conformational change in ANT distinct from 
its translocation role (14). 
 
F. ROS-induced proton leak 
 
Brookes (55) proposed that ROS and H+ leak comprise a loop 
not requiring UCPs to operate, but rather that the leak is dependent on 
the ΔΨm alone. A high ΔΨm would generate ROS (191), and the ROS 
would in turn induce an H+ leak to reduce the ΔΨm in a feedback 
manner. The generated O2•− could induce an H+ leak indirectly through 
a lipid oxidation product or possibly via protonation of O2•− in the 
acidic intermembrane space to HO2• (215), which is membrane 
permeableand is deprotonated in the alkaline matrix (104). A decrease 
in the phosphorylation to respiration (P/O) ratio (i.e., uncoupling), 
may come at the expense of higher ΔΨm and ROS. The higher, but less 
efficient, metabolic rate associated with H+ leak may be linked to the 
aging process (55). ROS could cause an H+ ‘‘slip’’ rather than an H+ 
leak. H+ slip is described as direct reduction of cytochrome c by the 
O2•− generated into the intermembrane space, thereby bypassing the 
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Qi site (55), as discussed earlier in this section. Instead of 8H+ 
pumped per 4e¯ at complex III, only 4H+ would be pumped per 4e¯; 
this effectively represents a 50% reduction in ATP synthesis capacity 
at a given level of respiration. 
 
VIII. Physiologic Modulation of Mitochondrial ROS 
Emission 
 
A. H2O2 and ONOO¯ as chemical effectors 
 
Despite rather efficient electron transfer along the respiratory 
system (i.e., little electron leak), one might ponder why the 
mitochondrion and its surrounding environment are incapable of 
removing all the ROS that are produced despite the well-developed 
and necessary scavenging systems. Or one could argue that natural 
selection allowed a system that uses ROS for cell signaling and even 
protection against damage. Although the mitochondrion is largely a 
sink for O2•− and H2O2 due to its ROS scavenger systems, it likely 
releases small amounts of H2O2 as a natural chemical messenger in the 
modulation of mitochondrial and cellular function (27, 113, 126, 183, 
203, 206). It was noted that the MnSOD knockout is lethal (204, 214), 
that MnSOD overexpression is associated with developmental 
abnormalities (264), and that ROS are required to trigger the apoptotic 
mechanism (68, 172, 207, 323), which is useful to actively eliminate 
poorly functioning cells and is required during embryonic development. 
It is now well known that ROS trigger or mediate ischemic and 
pharmacologic preconditioning of hearts (15, 27, 102, 181, 183, 248, 
254, 303). However, it is difficult to determine how much, from where, 
and what kind of ROS is beneficial versus detrimental. Although a 
therapeutic goal may be to reduce ROS emission, particularly during 
oxidative stress, too much scavenging or the wrong kind of scavenging 
may eradicate protective cellsignaling mechanisms, as we have shown 
(70) and several reviews (118, 163, 203, 235, 303) have suggested. 
 
The complex and extensive scavenging systems, the ROS/H+ 
leak-feedback relation, and the possible role of UCPs in H+ leak are 
several selected areas of research in which attempts have been made 
to understand the pathophysiologic regulation of ROS emission. It is 
evident that the bioenergetics state of mitochondria is important, not 
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only for generation of ROS but also for ROS scavenging, and therefore 
the regulation of ROS emission. For example, free fatty acids function 
as natural mild uncouplers by preventing the transmembrane 
electrochemical H+ potential difference (∆mH+) from being above a 
threshold critical for ROS formation by complexes I, III, or both (190). 
 
NO•, a well-known modulator of cell function, is not reviewed in 
detail here because its generation within mitochondria is debatable, as 
mentioned in section IV. However, the interaction of NO• and O2•− to 
form ONOO¯ and ONOOH as cell-toxic NO• derivatives is well known; 
but low concentrations of ONOO¯ (0.1mM) were found to protect 
neurons against NO•-mediated apoptosis by activating the 
phosphoinositide-3-kinase (PI3K)/Akt antiapoptotic signaling pathway 
(106). The activation was accompanied by an increase in oxidized 
phosphoinositide phosphatase (PTEN), indicating that activation of 
PI3K/AKt inhibited PTEN and the NO•-mediated apoptotic pathway. 
ONOO¯ also was shown to stimulate pentose phosphate pathway (PPP) 
activity and the accumulation of NADPH, an essential cofactor for 
glutathione regeneration, and to activate glucose-6-phosphate 
dehydrogenase (G6PD), an enzyme that catalyzes the first rate-
limiting step in the PPP (128). These and other studies [reviewed in 
(39)] indicate that low levels of ONOO¯, like low levels of H2O2, have a 
potential cytoprotective effect that could be explored therapeutically. 
 
B. ROS modulation by cations  
 
An additional area of focus recently is the role of cation 
exchangers and channels in modulating ROS and cell signaling. In 
developing the chemiosmotic theory of energy coupling, Mitchell (229) 
recognized that mechanisms must exist to exchange anions for OH¯ 
and cations for H+ in the IMM; otherwise, in creating the ΔΨm, the 
mitochondrion would swell and lyse, as only cations could leak in and 
anions leak out. Thus, mitochondrial cation antiporters (exchangers) 
were found to be necessary to regulate an osmotic differential across 
the IMM that would result from the high H+ electrochemical gradient 
(34, 131). The chemiosmotic hypothesis requires several 
electroneutral cation antiporters for H+ (NHE, Na+/H+ exchanger; and 
KHE, K+/H+ exchanger) and a low permeability to K+ and Na+ (34, 131, 
239). In this way, countercations to H+ would enter and leave the 
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matrix along their electrochemical gradients, thus preventing osmotic 
swelling. Modulation of extramatrix and matrix pH affects the 
protonation of O2•− and ONOO¯, as discussed in section III. 
 
C. K+: A modulator of ROS generation? 
 
The K+ cycle (Fig. 26) is believed to be an important element in 
modulating mitochondrial function (34, 130, 131, 133) and may 
modulate ROS release (9, 159). The importance of regulated pathways 
for both K+ uptake and K+ efflux may be that this flux regulates a very 
fine tuning of mitochondrial volume that affects the rate of respiration 
(149, 150). K+ may be taken up via one or more putative 
mitochondrial K+ channels on a stimulus of low ATP levels or increased 
Ca2+ (KATP, KCa). In isolated cardiomyocytes, it was reported that 
increases in ROS and NO• are downstream effects of application of a 
drug thought to open KATP channels (205), but we have found it 
difficult to observe significant increases in ROS with pharmacologic 
preconditioning agents, including K+ channel openers and anesthetics 
in isolated hearts (182, 183, 298). Figure 27 (from ref. 182) shows a 
small increase in ROS (ETH) in isolated hearts exposed to sevoflurane 
that was blocked by MnTBAP but not by the putative KATP antagonist 
5-HD. 
D. Biphasic effect of KCa channels on ROS generation 
 
We have postulated that mitochondrial KCa channels can 
modulate ROS production up or down by altering ∆pH independent of 
ΔΨm (158, 159). We proposed that opening KCa channels with NS1619 
produces a small H+ leak (Fig. 28) (159). Others have proposed that 
K+ cycling can account for no more than a small H+ leak (49, 50). The 
increase in K+ influx may be rapidly matched by K+ efflux and H+ influx 
via KHE driven by the pH gradient. As K+ enters the matrix 
electrophoretically via K+ channels (e.g., during ischemia due to Ca2+ 
loading and low ATP during ischemia) K+ may be exchanged for the 
energetically more favorable entry of H+ (leak) because of the large 
∆pH. If the inward H+ leak is small, a small increase in proton pumping 
by complexes I, III, and IV enhances the respiratory rate without 
decreasing ΔΨm, while promoting ROS release (Fig. 29). K+ flux could 
be a mechanism by which increased matrix Ca2+ modulates 
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respiration.When the H+ leak is large, ΔΨm (and O2•− generation) 
would decrease, as discussed with other mechanisms of the H+ leak 
(section VI).  
 
If K+ flux mediates an H+ leak through KHE, then blocking KHE 
(quinine) should increase matrix K+ but not H+ levels. In preliminary 
experiments in isolated cardiac mitochondria, we observed that 
valinomycin, the putative KCa channel opener NS1619, and buffer Ca2+ 
increased matrix K+ only in the presence of KHE blockade and that 
matrix pH decreased only in the absence of KHE (3, 4). A caveat to our 
work is that NS1619 has been reported (74) also to act as a 
protonophore, in which case, a small direct H+ leak, rather than K+ flux 
and KHE, might lead to the increase in H2O2 if ΔΨm remains 
unchanged. Thus, although a large proton leak would be expected to 
act as a brake on further ROS generation, a small proton leak that 
stimulates respiration without reducing ΔΨm may actually slightly 
increase ROS to modulate cell-signaling pathways. Moreover, in a 
recent study in which K+ flux across the matrix was assessed indirectly 
by swelling and respiratory changes induced by valinomycin (K+ 
ionophore) and nigericin (KHE activator), the putative K+ channel 
openers NS1619 and diazoxide could not be shown to enhance K+ flux 
(30). 
 
E. KATP channel opening and ROS 
 
A putative mitochondrial KATP channel opener was also reported 
to increase ROS production (Fig. 30), but by an alternative mechanism 
(9). In the presence of ATP, diazoxide increased ROS in isolated 
mitochondria, and the effect was inhibited by 5-hydroxydecanoate (5-
HD); it was hypothesized that matrix K+ influx causes matrix 
alkalinization, which retards electron transfer at complex I to cause 
electron leak and ROS formation (9). 
 
The mitochondrial effects of drugs can be different, depending 
on the substrates used, their concentrations, and the bioenergetics 
state. For example, in isolated cardiac mitochondria, we found that 
two putative KATP channel openers (diazoxide and pinacidil) 
differentially attenuated mitochondrial respiration and that KATP 
channel antagonists (5-HD and glibenclamide) had no effect on this 
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(270). But when ATP synthase was inhibited by oligomycin, both KATP 
channel openers accelerated respiration, which was abolished by the 
KATP channel inhibitors. Many drugs also have biphasic effects, largely 
because they have concentration-dependent effects on mitochondrial 
energetics. For example, the various putative types of mitochondrial 
K+ channel openers at low concentrations accelerate respiration and 
ROS generation without altering ΔΨm or redox state (9, 159), whereas 
larger concentrations accelerate respiration even more, depolarize 
ΔΨm, and decrease the redox state and ROS generation (105, 130, 
159). Moreover, these openers may have primary (74, 162) or 
secondary (159) effects to induce a proton leak into the matrix and 
may not actually open mitochondrial K+ channels. 
 
Thus, drugs that act on mitochondria can have biphasic as well 
as nonspecific effects, which complicate our understanding of 
mitochondrial function. As noted elsewhere, all these findings in 
isolated mitochondria are highly condition dependent and may not 
represent what occurs in intact tissue preparations. Further studies are 
necessary to determine the mechanism and extent to which specific 
mitochondrial K+ channels do or do not modulate ROS at physiologic 
levels. That these channels are sensitive to either low ATP levels or 
high Ca2+ levels suggests that they could have important roles in 
mitochondrial regulation. Although many of the drugs used to assess 
ion channels in cell membranes may have specificity for a particular 
channel, the drugs used to assess mitochondrial channel function 
(e.g., diazoxide or NS1619) do not appear to be specific for these 
channels but nevertheless exert protective function by an uncoupling 
mechanism and or by stimulation of ROS-dependent pathways. 
 
F. Direct Ca2+-induced ROS unlikely 
 
Does Ca2+ directly modulate ROS? Ischemia and reperfusion 
result in increases in both Ca2+ and ROS, but it is unlikely that Ca2+ 
itself modulates ROS physiologically for the following reasons: (a) in 
pathologic situations, excess ROS results in Ca2+ loading, but not the 
other way around (72); (b) excess Ca2+ loading will itself cause MPT 
pore opening and dissipation of the ΔΨm (72), but ROS-induced MPT 
pore opening does not require Ca2+ loading (186); (c) a Ca2+-induced 
increase in oxidative phosphorylation (and decreased ΔΨm) tends to 
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decrease ROS, not to increase ROS (59, 72, 243, 296); (d) excess 
Ca2+ increases ROS only when mitochondrial inhibitors are used; 
otherwise, ROS decreases (59, 65); (e) blocking mitochondrial Ca2+ 
flux does not interfere with bursts of ROS produced by mitochondria 
during a local laser flash (11); and (f ) O2•−-induced mitochondrial 
swellingis Ca2+ independent, but Ca2+-induced swelling is ROS 
dependent (127, 194). However, the possibility that Ca2+-induced MPT 
pore opening, leading to loss of cytochrome c, differentially alters the 
matrix and IMS levels of ROS is discussed in section V. 
 
G. Rate of oxidative phosphorylation and ROS 
generation 
 
As discussed in section III, it is well known from O2-
consumption experiments in mitochondria that the state 3 to state 4 
transition is usually accompanied by enhanced ROS production. 
Uncoupling (increased respiration without increased phosphorylation) 
typically leads to reduced ROS production, so it is possible that a 
change in the rate of oxidative phosphorylation modulates the rate of 
O2•− generation. Moderate increases in m[Ca2+] induced by cell-
receptor stimulation have long been thought to stimulate TCA-cycle 
substrate dehydrogenases and ATP synthase (108, 227, 228). 
However, it appears that this Ca2+-induced stimulation is a slow 
process, because the dynamic, rapid stimulation of oxidative 
phosphorylation is not inhibited by partially blocking mitochondrial 
Ca2+ entry (148). Oxidative phosphorylation is activated with a time 
constant of seconds for the creatinine kinase system with an increase 
in ATP hydrolysis (313) that is too fast for Ca2+ to enter the matrix 
(52, 232). The prevailing view has been that oxidative phosphorylation 
is not governed by feedback control (17, 18, 51, 52, 180, 226). 
Computer simulations of increased cardiac work demands indicate that 
neither direct activation of ATP use alone nor a direct activation of 
both ATP use and substrate dehydrogenation, including Ca2+-
dependent TCA-cycle dehydrogenases, can account for the constancy 
of [ATP], [PCr] [Pi], and [NADH] during an increase in O2 consumption 
in hearts in vivo (192, 193). Rather it was proposed that a so-called 
‘‘each- step-activation’’ (or parallel-activation) mechanism is the 
explanation, in which all oxidative phosphorylation complexes are 
directly activated by some cytosolic factor related to muscle 
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contraction in parallel with activation of ATP use and Ca2+-dependent 
TCA-cycle dehydrogenases. This is a broad concept difficult to 
disprove. Others have proposed that oxidative phosphorylation in the 
heart is not likely regulated by quickly diffusing ADP and Pi in a simple 
feedback-control system (314). But another computer simulation (26), 
which incorporated each respiratory complex, substrate transporters 
including ANT, and cation fluxes, obtained reasonable fits to published 
data if Pi-dependent activation of dehydrogenase activity and the 
electron-transport system (especially complex III) were incorporated. 
Further development of this model (329) predicted that NAD is a more 
important regulator than ADP of the TCA-cycle dehydrogenases, and 
that a decrease in cytosolic pH decreases ΔΨm and the ability to 
synthesize ATP.  
 
Phosphorylation of complex IV at high matrix ATP/ADP ratios is 
known to decrease the H+/e¯ stoichiometry (H+‘‘slip’’) of the complex 
inducing an intrinsic form of uncoupling in which the efficiency of 
proton pumping is reduced (see also section VII). Respiratory control 
is generally defined as the increase in respiration in the presence of 
ADP and its decline once ADP is phosphorylated. A possible mechanism 
for control of ROS release by oxidative phosphorylation may arise from 
a ‘‘second mechanism of respiratory control,’’ in which a high matrix 
ATP/ADP ratio is thought to allosterically inhibit complex IV (219). This 
inhibition of cytochrome c oxidase is switched on by cAMP-dependent 
phosphorylation and switched off by Ca2+- activated dephosphorylation 
(179). cAMP-dependent phosphorylation of cytochrome c oxidase may 
optimize the efficiency of oxidative phosphorylation by maintaining a 
low ΔΨm via the second mechanism of respiratory control. The effect of 
NO• to compete with O2 for binding at complex IV is discussed in 
section IV. Extrinsic uncoupling (H+ ‘‘leak’’) of oxidative 
phosphorylation (e.g., UCPs, HNE) is described in section VII. 
 
IX. Role of ROS in Triggering or Effecting 
Cardioprotection 
 
A. Pathways and mechanisms 
 
Preconditioning is defined by the removal of the stimulus (brief 
ischemia or drug) some time before the onset of ischemia. Thus, the 
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stimulus does not directly induce the cardioprotection but rather some 
downstream factors do. Much circumstantial evidence suggests that 
mitochondria- derived ROS play an important role to initiate ischemic 
preconditioning (IPC) (Fig. 19) and pharmacologic preconditioning 
(PPC) (90, 100, 101, 217, 271, 306), which is effected by protein 
kinase pathways (223, 224, 247). Earlier studies examined the role of 
KATP channel openers and inhibitors to elicit and to block PPC. A 
common denominator of these studies was the finding that PPC, 
induced by the putative mitochondrial KATP channel opener diazoxide, 
could be blocked by ROS scavengers such as N-acetylcysteine (124) or 
N-mercapto-propionyl-glycine (254). A mild ROS stress, per se, 
triggered cardioprotection by activating protein kinases, but ROS also 
were reported to activate sarcolemmal KATP channels by modulating 
ATP binding at this channel, as this effect was blocked either by 
glibenclamide or by ROS scavengers (304, 305). Conversely, IPC 
requires ROS independent of KATP channel activity (120). Both KATP 
channel opening and H2O2 inhibit MPT pore opening (94). These and 
other studies suggested that a feedback loop may exist between KATP 
channels and ROS to produce cardioprotection (205, 237, 272, 298, 
299), but much of this remains unresolved, in part because many of 
the drugs used as probes have other effects on cell or mitochondrial 
function (103, 154–156, 259). Kukreja (198) addressed the 
controversy in this area.  
 
Mitochondrial Ca2+-dependent K+ channel (KCa) as well as KATP 
channel openers may play major roles not only in modulating 
mitochondrial bioenergetics but also in cardioprotection against 
ischemia/reperfusion injury. Most is reported about the putative KATP 
channel (1, 130, 131, 178, 195, 236). Mitochondrial KCa openers, like 
KATP channel openers, appear to mediate their effects through ROS-
dependent mechanisms, as ROS scavengers, such as MnTBAP, block 
the protection (Figs. 18 and 19) (181, 183, 298). Figure 31 shows that 
paxilline (PX, an inhibitor of KCa channels) and MnTBAP (TB, an O2•− 
dismutator) blocked the ROS (DHE) and redox (NADH) reducing effect 
of NS119 (putative KCa channel opener) during ischemia and 
reperfusion of isolated hearts. Diverse cardiac-preconditioning drugs 
given before ischemia and reperfusion in isolated hearts result in 
improved function along with improved tissue redox state (NADH and 
FAD), reduced cytosolic and mitochondrial Ca2+ loading, and reduced 
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production of O2•− and ONOO¯ during ischemia and reperfusion (76, 
181, 248, 298). If the observed changes in isolated mitochondria by 
mild K+ flux that promotes the increase in O2•− (observed via 
dismutation to H2O2) also occur in vivo, then modulation of 
mitochondrial bioenergetics by K+ flux might ultimately be a key 
initiator of mitochondrial and cell protection. 
 
B. Inhibiting complex I and cardioprotection 
 
Another approach to protect cells undergoing ischemia is to 
inhibit complex I during ischemia (81). Rotenone or amobarbital (a 
reversible inhibitor of complex I) given just before the onset of cardiac 
ischemia resulted in improved oxidative phosphorylation and retention 
of cytochrome c in mitochondria isolated during ischemia or on 
reperfusion (82, 85). We found subsequently that amobarbital, per se, 
when given for 1 min before ischemia, arrested hearts, increased O2•− 
emission (and NADH, with no change FAD), and reduced mitochondrial 
[Ca2+] (Fig. 32) (5); this led to reduced O2•− generation and 
mitochondrial [Ca2+] during ischemia and reperfusion. These ex vivo 
results suggested that amobarbital blocks electron transfer upstream 
of the rotenone binding site but distal to the NAD+ binding site. During 
reperfusion after ischemia, we observed a more reduced NADH redox 
state, decreased O2•− generation, and reduced mitochondrial [Ca2+] in 
this intact heart model (5). These mitochondria-protective effects were 
accompanied by improved cardiac function and smaller infarct size. 
 
X. Regulation of Cellular Processes by 
Mitochondria-Derived ROS 
 
Intracellular signaling pathways (e.g., Ca2+, cAMP, protein 
phosphorylation–dephosphorylation cascades) are essential for 
modulating cell metabolism and function. Many of these pathways are 
linked to extracellular receptor ligands at the plasma membrane, but 
many are derived from within the cell (e.g., the feedback link between 
the cell’s metabolic rate and mitochondrial respiratory activity). 
Accumulating evidence indicates that ROS are not always deleterious 
but are essential participants in cell signaling (113, 126, 163, 303). 
Whether ROS are ‘‘bad’’ or ‘‘good’’ could simply be a matter of quantity 
or rate of production, or it may also depend on the specific species, 
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the site of generation, and the site of ROS release. The important and 
well-examined role of non–mitochondriaderived ROS (O2•− and NO•) in 
vascular sensing and control (328) is not addressed here. The 
‘‘pathologic’’ roles of ROS and Ca2+ loading during cellular stress [e.g., 
ischemia, hypoxia that lead to induction of cell necrosis and apoptosis 
(68, 207, 323, 330)] were addressed in section III. 
 
A. Cell signaling by oxidative modifications and redox 
systems 
 
ROS-induced cell signaling involves two general mechanisms: 
alterations in the intracellular redox state (e.g., GSH, TRXSH2, and 
other redox systems) (Fig. 21) and oxidative modification of proteins 
(92, 303). ROS appear to regulate a large number of signaling 
pathways that modulate cell function, but the actual molecules 
targeted by the ROS are unclear in most cases. Evidence for a 
physiological role of ROS emission are based in part on the effects of 
antioxidants and inhibitors of ROS generation to prevent growth factor 
and cytokine-activated signals, or some other physiological effect, and 
the effects of exogenously applied oxidants to activate these  
responses.  
 
Synchronized oscillations in ΔΨm, the redox states of 
NADH, GSH/GSSG and other redox pairs, and ROS can occur across 
isolated cardiomyocytes (11) and were postulated to result from the 
balance between O2•− efflux through IMM anion channels (IMAC) and 
the intracellular ROS scavenging capacity. This was based on a 
computational model (93) of mitochondrial energetics and Ca2+ 
handling that reproduced the observed oscillations, which could be 
modulated by ROS scavengers or by the rate of oxidative 
phosphorylation. Oxidation of thiol groups appears to govern the 
sequential opening of IMAC (before MPT pore opening occurs), based 
on the GSH/GSSG redox status (10). Such oscillations may play a role 
in physiologic timekeeping or redox signaling across the cell or both. 
 
B. Examples of signaling by ROS 
 
The role of ROS in initiating preconditioning protection, 
particularly well known in the heart, is a vivid example of how ROS 
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modulate cell signaling by mitochondrially generated ROS. To be a 
modulator of physiological function, the oxidizing effect of ROS should 
be transient and reversible, generally by other reducing agents. Broad 
examples of ROS (typically H2O2)-induced signaling (266) are inhibition 
of tyrosine phosphatase (278, 315) leading to cell proliferation; 
translocation and activation of serine/threonine kinases, such as 
protein kinase C (247, 301) and tyrosine hydroxylase mRNA, the rate-
limiting enzyme in catecholamine biosynthesis (196); activation of the 
MAPK family of protein kinases (including MAPKs ERK, JNK, p38) that 
mediate mitogen and stress-activated signals; NF-кB, a transcription 
factor that regulates gene expression involving immune and 
inflammation responses; and AP-1, a transcription complex (303). 
 
One example of a regulatory feedback loop between ROS 
signaling and enzyme modification is the following: pyruvate was 
shown to activate JNK1 indirectly via pyruvate-induced mitochondrial 
H2O2 release (242); in turn, JNK1 inhibited the activity of the 
metabolic enzymes glycogen synthase kinase 3β, allowing increased 
activity of glycogen synthase so that glucose was stored as glycogen 
rather than undergoing glycolysis. Thus substrate metabolism can be 
tied directly to mitochondrial ROS. Ion-channel function is also subject 
to modification by thiol reducing and oxidizing agents (73, 163, 164). 
 
C. Importance of cysteine thiols in ROS-induced 
signaling 
 
How ROS modify the structure and function of these and other 
signaling proteins is not well understood, but several mechanisms are 
described (163, 303), particularly those involving the key thiol groups 
in regulatory proteins (20). One is the reversible oxidation of the 
sulfhydryl group (―SH) in the cysteine residue to form SOH, SO2H, or 
SO3H derivatives that alter the activity of an enzyme if the cysteine is 
located in a catalytic domain or DNA-binding site. For example, H2O2- 
induced oxidation of a cysteine residue located in its catalytic site 
precisely and rapidly inhibits tyrosine phosphatase (278, 315). The 
modification of –SH to –SO2H prevents the enzyme from further 
oxidation and promotes reversibility to its active form (except for 
SO3H) by thiols (278, 315). 
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Another mechanism for posttranslational protein modification by 
ROS (Fig. 7) is a conformational change in the structure of protein 
kinases by formation of intramolecular disulfide bridges in cysteine 
linkages. Another is protein dimerization by intermolecular disulfide 
linkages of monomers to form an active protein, or dissociation of an 
inactive protein complex linked by disulfide linkages into an active 
protein. Several proteins can also become cross-linked because of 
active dityrosine formation from two tyrosine molecules by H2O2 
peroxidase–dependent reactions. Mixed-function oxidases can facilitate 
metal-catalyzed oxidation by O2•− of proteins with 4Fe-4S tetranuclear 
cores to mark them for ubiquitination and so alter their stability (303). 
To qualify as cell-signaling pathways, these oxidation reactions should 
be reversible by using the cell’s redox systems (e.g., GSH and 
TRXSH2), as discussed previously. 
 
D. ROS oxidation reactions 
 
Precursor ROS do not always oxidize proteins directly but rather 
through an oxidized and reactive phospholipid intermediary (Fig. 23). 
Oxidized lipids can activate cellsignaling pathways by non-covalent 
bonding to a receptor, by covalent binding with direct modification of 
the protein, and by activating pathways that induce ROS formation 
from other sources (334). The electrophilic lipid peroxidation product 
4-HNE (section VI) causes ROS emission that activates MAPK 
pathways (311), and 4-HNE selectively inactivates thiol containing 
proteins, such as a-ketoglutarate dehydrogenase and pyruvate 
dehydrogenase, and thus inhibits NADH-dependent respiration 
(complex I) (168). 
 
E. O2 sensors 
 
A physiologic response to low O2 requires an O2 sensor coupled 
to a signal-transduction system (80). For example, ATP synthesis is 
tightly proportional to O2 consumption in the presence of adequate O2, 
so the ability of the cell to sense a critically low level of O2 would 
appear to be fundamental to restoring O2 levels for ATP synthesis (45). 
But the molecular identity or mechanism of an O2 sensor has not been 
forthcoming. Several O2-sensor mechanisms have been proposed and 
reviewed (80): O2-sensitive heme proteins; O2-sensitive ion channels; 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Antioxidents and Redox Signaling, Vol. 11, No. 6 (June 2009): pg. 1373-1414. DOI. This article is © Mary Ann Liebert, Inc. 
and permission has been granted for this version to appear in e-Publications@Marquette. Mary Ann Liebert, Inc. does 
not grant permission for this article to be further copied/distributed or hosted elsewhere without the express permission 
from Mary Ann Liebert, Inc. 
42 
 
O2-sensitive NADPH oxidase; O2-sensitive complex IV; and O2-
sensitive ROS generation. Many of the proposed O2 sensors do not 
appear to have the sensitivity to act directly as O2 sensors, but they 
could all be linked to hypoxia-induced changes in redox state or ROS 
generation. For example, the capacity of complex IV to produce H2O 
from O2, electrons, and protons is not impaired at even very low p2 
values, but enzyme activity (Vmax) is reduced so that reduced electron 
transfer and a more reduced redox state ensue (80). 
 
F. Hypoxia-inducible factors 
 
A principal regulator of the response to hypoxia is the hypoxia-
inducible factor (HIF) family of transcription factors (31, 61, 115, 165, 
177, 185, 221, 282–286, 316, 327). Although constitutively 
expressed, the HIF-1 subunit has a very short half-life in normoxic 
conditions because of its rapid hydroxylation by prolyl-4 hydroxylases 
(PH1–3) (12, 36). During hypoxia, the HIF-1 subunit becomes 
uninhibited by PHs, so that HIF-1 accumulates and transfers to the 
nucleus to initiate HIF-1-mediated transcription of more than 70 
genes involved in protein stability, such as heat-shock proteins (HSPs) 
(40). Therefore, low O2 would appear to control activation of HIF-1 by 
inhibiting PH activity. The mitochondrion would seem to be a natural 
sensor for O2 because complex IV is where O2 binding and O2 
consumption occur. However, blocking complex III with antimycin A 
and cyanide to block complex IV did not inhibit the HIF-1 in isolated 
cardiomyocytes in response to hypoxia (79). Moreover, inhibition of PH 
did not occur until O2 levels were below 5%, with maximal activation 
at 0.5% O2 (177). Rather than O2 being the actual sensor, it was 
proposed that the actual sensor is the redox changes upstream from 
complex IV (146). 
 
The signaling consequences of hypoxia are probably modified by 
NO•. Nitric oxide, and other inhibitors of mitochondrial respiration, can 
prevent stabilization of HIF-1 during hypoxia as a result of an 
increase in PH-dependent degradation of HIF-1 (147). During 
inhibition of mitochondrial respiration by hypoxia, O2 was found to 
redistribute toward nonrespiratory O2-dependent targets such as PHs, 
so that they no longer registered hypoxia (147). It was concluded that 
NO• acts as an endogenous regulator of intracellular O2 availability; 
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inhibition of mitochondrial O2 consumption may create a paradox of 
increased O2 availability for prolyl hydroxylation of HIF-1, so that the 
cell may fail to register hypoxia. In a related study (222), lower 
concentrations of NO• (<400 nM) caused a rapid decrease in HIF-1 
stabilized by exposing cells to 3% O2. This effect of NO• was 
dependent on inhibition of mitochondrial respiration, because the NO• 
effect was mimicked by other inhibitors of mitochondrial respiration, 
including those not acting at complex IV. It was suggested that 
although stabilization of HIF-1 by high level of NO• may have 
pathologic consequence, the inhibitory effect of low levels of NO• may 
be physiologically relevant. 
 
G. ROS as O2 sensors 
 
It has been suggested that O2 sensing by the cell is actually 
carried out by mitochondrial ROS (31, 61, 80, 146, 221), including NO• 
(57). One proposal is that the increase in mitochondrial redox state 
secondary to the reduced Vmax of complex IV during hypoxia creates a 
more favorable condition for O2•− generation and downstream ROS 
production (Fig. 33) (80). Thus, the common denominator for O2 
sensing by ROS would be the heightened redox state and ΔΨm or both. 
However, the mechanism for the reduction in Vmax by low O2 levels is 
not known. 
 
Support for a role of ROS in HIF-1 stabilization derives from 
studies showing that the absence of cytochrome c or blocked Rieske 
Fe-S proteins under hypoxic conditions blocks HIF-1 stabilization (61, 
221). How H2O2 inhibits PH activity is not yet known, but likely 
involves one of the ROS- induced protein modifications discussed 
earlier. When iron chelators were given to block Fe2+ from reacting on 
PH, or HIF-1 hydroxylation was prevented by 1-dimethyloxallyl 
glycine (DMOG) to compete at PH, HIF-1 accumulated and induced 
gene expression (173). These mechanisms depend on the observed 
increase in mitochondrial ROS in cells when O2 levels decrease during 
hypoxia and ischemia. However, this must be reconciled by the finding 
in isolated mitochondria that hypoxia does not itself increase ROS (Fig. 
20) (161). Thus, it has been proposed that the hypoxic signal is a 
decrease in ROS, not an increase (13, 184, 233, 326). Studies in intact 
cells, tissue and isolated hearts indicate that ROS emission increases 
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during hypoxia and ischemia, as discussed earlier (section III), so the 
controversy on the actual hypoxia-sensing mechanism continues. 
 
H. Peroxide-induced TCA shunts 
 
Peroxides produced by mitochondria can create nonenzymatic 
shunts in the TCA cycle (56, 121). Succinate dehydrogenase (complex 
II) is very resistant to oxidation by H2O2 or tert-butyl hydroperoxide 
(tert-BuOOH) (250), but -ketoglutarate dehydrogenase activity is 
markedly decreased (168, 250) because of its susceptibility for 
modification by peroxides of its thiol groups (167, 249). Although this 
decreases the enzymatic conversion of -ketoglutarate to succinyl 
Co-A and succinate by decarboxylation and blocks production of 
reducing equivalents (NAD+ to NADH) at this step, these oxidants 
nonenzymatically (chemically) decarboxylate -ketoglutarate to 
succinate and thus reduce the level of peroxides (Fig. 34) (121). This 
bypass depends on a supply of -ketoglutarate by transamination 
because its precursor, aconitate, is also inactivated by peroxides (62, 
249). This TCA bypass increases the contribution of succinate to the 
total energy supply (FADH2 dependent) while decreasing the NADH-
dependent energy supply (168). Because succinate can contribute to 
reverse electron transfer and generation at complex I under certain 
conditions, control of succinate levels during acute cell stress may be 
beneficial. Another peroxide bypass, the electron-leak pathway 
mediated by cytochrome c (332, 333), was discussed in section VII. 
 
Hypoxia, increased succinate, and decreased aketoglutarate can 
each lead to inhibition of PH (208, 281), which permits translocation of 
HIF- to the nucleus to support HIF-–dependent transcription of the 
multitude of genes responsible for O2 transport, vascularization, and 
anaerobic energy production (208). Addition of succinate improved 
oxidative phosphorylation after ischemia/reperfusion injury (69), so 
the role played by succinate is not well understood. These studies 
again point to H2O2 (and other peroxides), rather than O2•− per se, as 
the transduction factor in physiologic regulation by ROS (61). 
Modulation of a key TCA intermediate, in this case succinate, by ROS is 
a prime example for demonstrating how mitochondria and cells 
respond to oxidative stress by altering gene expression. If ischemia or 
hypoxia induces reverse electron transfer by a TCA shunt to the FAD-
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linked substrate succinate because of inhibition of the NADH-linked 
substrates, the resulting increase in O2•− generation at complex I may 
signal measures to alter mitochondrial function. It was noted earlier 
that inhibiting complex I with amobarbital improved cardiac function 
after ischemia and reperfusion and improved mitochondrial function 
(5, 85). Thus, it is possible that reverse electron transfer may be, at 
least in part, responsible for some of the increase in ROS during 
ischemia. As discussed in section III, NADH-linked substrates do not 
appreciably block succinate-induced H2O2 emission via reverse electron 
transfer (335). 
 
XI. Summary 
 
A. Difficulties in understanding the role of ROS 
 
Although H2O2, and in some situations, O2•- (21), are found to 
trigger a multitude of signaling pathways (most unknown) via their 
reactants such as peroxides, the precise mechanisms by which 
mitochondrial ROS initiate the signal-transduction pathways are mostly 
unknown, despite the TCA succinate bypass example given earlier. 
One difficulty in a better understanding of ROS modulation of cell 
signaling is the short half-life and reactive state of many ROS. The 
source or compartmentalization of the ROS is difficult to discern in 
most situations. The original oxidation product may itself be oxidized 
to a product that is the active signaling molecule. A surge in ROS or 
changes in redox capacity may have local or broad effects on many 
regulatory proteins simultaneously, so determining specificity is 
difficult. The ROS can originate from extracellular, cytosolic, or a 
nonmitochondrial organelle, or from a combination of extra- and 
intramitochondrial compartments. Moreover, redox regulation of ROS 
occurs at multiple levels. All of these complicating factors make it quite 
difficult to sort out the exact signaling mechanisms of ROS. It would 
appear that Nature has developed a highly sophisticated system to 
regulate specifically the generation and scavenging of ROS and to 
modulate the downstream effects of physiologically induced ROS 
emission on mitochondrial and cell activity. 
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B. Future directions 
 
From this review, it is clear that much has been learned about 
mitochondrial sources of ROS, the mechanisms of ROS generation and 
scavenging, and the pathologic effects of ‘‘bad’’ ROS on cell processes. 
However, knowledge of the source, amount, generation site, and 
specific ‘‘good’’ reactive species that are involved in cellular and 
organelle protection and physiologic modulation of cellular activity, 
even in one cell type (e.g., the cardiac myocyte), remains in its 
infancy. We hope that future studies will refine and detail our specific 
understanding of cell-signaling pathways mediated by mitochondrial 
ROS by using more physiologic approaches in normal cell settings. 
From these studies, it is hoped that novel therapeutic targets and 
drugs can be discovered by which to treat mitochondrial and cellular 
stresses, or at least to assist the organism’s intrinsic protective 
mechanisms. 
 
Footnotes 
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Fig.1. 
Schema of electron transfer through respiratory chain with sites of 
ROS (O2•−) generation at complexes I and III. Electron transfer is 
reversible, except at complex IV, and forward transfer results in extramatrix 
proton pumping at complexes I, III, and IV, with reentering of protons at 
complex V coupled to ATP synthesis. Succinate can lead to reverse electron 
transfer, reduction of NAD+ to NADH, and O2•− generation at complex I. [Used 
with permission and modified from Batandier et al. (22)]. 
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Fig. 2 
(A) Sites of O2•− generation along electron-transport system with 
several respiratory inhibitors. (B) Diagram of electron-transport system 
with standard reduction potentials (Eo') of mobile components and ΔEo' where 
sufficient free energy is harvested to synthesize ATP. 
 
 
Table 1. 
Examples of Reactive Oxygen (Nitrogen, Chlorinating) Species 
Radicals Nonradicals 
Superoxide, O2•− Hydrogen peroxide, H2O2 
Ferryl, Fe(IV) = O• Hypochlorous acid, HOCl 
Peroxyl, RO• Oxone, O3 
Alkoxyl, RO• Singlet oxygen, 1ΔgO2 
Nitric oxide, NO• Peroxynitrite, ONOO− 
Hydroperoxyl, HO2• Peroxynitrous acid, ONOOH 
Note that not all radicals (O2•−) or nonradicals (H2O2) are highly reactive, 
whereas other radicals and nonradicals are highly reactive (HO2•, ONOOH). 
Carbon-centered radicals (Cl3C•), sulfur-centered radicals (RS•/RSS•), and 
nitrogen-centered radicals (C6H5N = N•) also exist (151). 
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Fig. 3 
The products of superoxide (O2•−) and their catalysts. 
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Fig. 4 
EPR spectra indicating formation of O2•− (DMPO-OH signals) by 
mitoplasts. The O2•− spin-trap DMPO and antimycin A (B) are necessary to 
observe the signals (Control; A), which are abolished by SOD (C). 
Succinate + antimycin A (D). [Reprinted with permission from Han et al. 
(152)]. 
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Fig. 5 
Representative traces of H2O2 emission rates (amplex red, HRP) 
during 10 mM succinate–supported respiration in guinea pig heart 
isolated mitochondria. H2O2 emission was abrogated (A) by adding 4 μM 
carbonyl cyanide m-chlorophenylhydrazone (CCCP), a mitochondrial 
uncoupler, or by 4 μM rotenone (B), a complex I blocker. H2O2 emission 
during pyruvate (complex I substrate, 10 μM)-supported respiration (C). 
Catalase (300 U/ml) was added to scavenge the H2O2 generated, and 5 μM 
antimycin A (AA) was added to enhance the H2O2 generated at complex III. 
Note the lower rate of H2O2 emission with pyruvate than with succinate 
(reverse electron transfer). afu, arbitrary fluorescence units. Numbers are 
changes in afu/min. [Reprinted with permission from Heinen et al. (158)]. 
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Fig. 6 
DHE (dihydroethidium) fluorescence (O2•−) during perfusion of 
guinea-pig isolated hearts at 37°C and 17°C with and without four 
drugs. Cardiac cooling markedly increased O2•− emission. MnTBAP, a SOD 
mimetic, reduced O2•− emission, and menadione (vitamin K3), an electron-
transport inhibitor, increased O2•− emission, whereas BDM (butanedione 
monoxime), a contractile inhibitor, and L-NAME (NG-nitro-l-arginine methyl 
ester), an inhibitor of NO• synthesis, had no effect on O2•− emission. DHE is 
thought to react with O2•− to form 2-OH-E+, which produces a transient red 
spectral shift. [Reprinted with permission from Camara et al. (71)]. 
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Fig. 7 
Dityrosine (diTyr) fluorescence (ONOO−) during perfusion of guinea-
pig isolated hearts at 37°C and 17°C with and without four drugs. 
Cardiac cooling markedly increased ONOO−. MnTBAP, a SOD mimetic, and L-
NAME (NG-nitro-l-arginine methyl ester), an inhibitor of NO• synthesis, both 
reduced ONOO−, whereas menadione (vitamin K3), an electron-transport 
inhibitor, increased ONOO−, and BDM (butanedione monoxime), a contractile 
inhibitor, had no effect on ONOO−. [Reprinted with permission from Camara 
et al. (71)]. 
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Table 2. 
Drugs Commonly Used to Assess Deductively the Sites of Electron Leak and 
Superoxide Generation within the Respiratory Chain 
Drug Mechanism Effect 
Complex I sites Inhibitors of NADH oxidation   
Rotenone (ROT) 
Inhibits transfer of e− from Q-binding site 
to complex I 
+ O2•− 
Amobarbital (AMO) 
Blocks transfer of e− from QNf to QNs distal 
to N2 Fe/S center 
+ O2•− 
Piericidin A (PCA) 
Inhibits e− by competing with QB for 
binding site in complex I 
+ O2•− 
Complex II sites Inhibitors of succinate dehydrogenase   
Malonate (MAL) Competitive inhibitor of complex II + O2•− 
Methylmalonate 
(MML) 
Competitive inhibitor of complex II + O2•− 
3-Nitroproprionate 
(3NP) 
Irreversible inhibitor of complex II + O2•− 
Atpenins (APT) Noncompetitive inhibitor of complex II + O2•− 
Complex III sites Inhibitors of quinone (Q) cycle   
Stigmatellin (STG) 
Prevents transfer of 1ste− from QH2 to 
Fe/S protein (ISP) 
± O2•−a 
Myxothiazol (MYX) Prevents binding of QH2 at Qo site + O2•− 
Antimycin A (ANA) Prevents transfer of 2nde− to Q1 site + O2•− 
Complex IV sites Inhibitors of O2 binding   
K+ cyanide (KCN) Allosterically inhibits cytochrome oxidase ± O2•−b 
Na+ azide (NaN3) Allosterically inhibits cytochrome oxidase ± O2•− 
Carbon monoxide 
(CO) 
Competes with binding of O2 to 
cytochrome oxidase 
± O2•− 
Nitric oxide (NO•) 
Competes with binding of O2 to 
cytochrome oxidase 
± O2•− 
  General oxidants   
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Drug Mechanism Effect 
Menadione (vitK3) 
Stimulates redox cycling by one e− 
reductive enzymes 
+ O2•− 
Quinones, 
doxorubicin 
Reacts with Fe3+ compounds to produce 
Fe2+ + e− 
+ O2•− 
H2O2 
Reacts with Fe compounds to produce 
Fe(IV = O)•  and Fe+3 + •OH + -OH Fenton 
effect (minor) 
+ •OH 
Note: Effects of some drugs on O2•− generationa,b depend on the substrate 
used and whether other drugs that act on the respiratory system are present. 
+, increase; −, decrease. 
Fig. 8. 
Schema of proposed O2•− generation sites in complex I at FMN 
(flavin), Fe-S centers N1–N5, and/or Q binding sites (A–C, circles). 
Electron transport can be forward (solid arrow) or reverse (dashed arrow); 
O2•− release is into the matrix only. SDH, succinate dehydrogenase. [Used 
with permission of and modified from Brand et al. (48)]. 
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Fig. 9 
Model of O2•− generation during forward (top) and reverse (bottom) 
electron transfer within complex I. During forward transport (substrate 
pyruvate), e− are passed from NADH to Q in a quinone-reducing site via the 
FMN and Fe-S centers. The resulting QH• is reduced in a ΔpH-dependent 
generating step to form QH2 with another e− from QH2 or QH• at the quinol 
oxidation site. O2•− generation is low unless Q-site inhibitors are present and 
the ΔpH is large. During reverse transport (substrate succinate), e− are 
passed from QH2 to NAD, so that the pool is reduced to NADH. A large ΔpH 
drives the formation of QH•, which loses its unpaired e− to O2 because all 
redox centers upstream of Q are fully reduced. [Used with permission of and 
modified from Lambert and Brand (200)]. 
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Fig. 10 
H2O2 production is more dependent on mitochondrial ΔpH than on 
ΔΨm during reverse electron transfer at complex I. This is suggested by 
the dependence of H2O2 production on ΔΨm when ΔpH is present (a) or 
absent (b); the difference (c) represents H2O2 production as a function of 
ΔpH. ΔpH was abolished with nigericin (b), which converts any ΔpH into ΔΨm. 
[Reprinted with permission from Lambert and Brand (201)]. 
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Fig. 11 
Mechanisms of O2•− formation from complex III. Oxidation of quinol 
(QH2) results in transfer of a single e− to a high-reduction-potential chain at 
the Qo (extramatrix) site containing the Fe-S protein (ISP, Rieske protein) and 
on to cytochrome c1 and cytochrome c, and finally to cytochrome c oxidase. 
The remaining QH• is unstable and donates the second e− to a low-reduction-
potential chain consisting of cytochrome bl (low) and bh (high), leading the e− 
toward the Qi (matrix) site to form a stable QH•; this QH• is then reduced to 
QH2 by a subsequent e− passed along the low-reduction-potential chain, 
thereby completing the Q–QH2–Q cycle. In (A), antimycin A causes 
extramatrix release of O2•−; in (B), stigmatellin and myxothiazol block 
antimycin A from releasing O2•−. [Used with permission of and modified from 
Andreyev et al. (8)]. 
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Fig. 12 
Highly reduced and coupled mitochondria (high ΔΨm and limited 
respiration due to lack of ADP) leak e− for attack by O2 because QH• is 
not as rapidly reduced to QH2. Progressive uncoupling by using a 
protonophore (SF6847) gradually reduces ΔΨm and increases respiration while 
markedly preventing H2O2 generation. A similar effect occurs during state 3 
with added ADP. [Reprinted with permission from Korshunov et al. (191)]. 
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Fig. 13 
Isolated mitochondria can produce H2O2 during state 3 (ADP 
stimulated) as well as during state 4 conditions during forward 
electron flow, provided that [O2] and mitochondrial protein 
concentration are sufficient. [Reprinted with permission from Saborido et 
al. (276)]. 
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Fig. 14 
ROS production at complex I in cardiac mitochondria is critically 
dependent on a highly reduced NADH pool. Downstream inhibition of 
electron transfer (respiration) by rotenone leads to reduction of all upstream 
carriers and results in e− leak and ROS generation. Note the large decrease in 
respiration rate and the increasingly reduced redox state with rotenone 
associated with ROS production during state 3 (left) compared with state 4 
(right). [Reprinted with permission from Kushnareva et al. (199)]. 
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Fig. 15 
DHE (dihydroethidium) fluorescence (O2•− emission) increases during 
perfusion of guinea-pig isolated hearts during intermittent (A) and 
continuous (B) cooling from 37°C to 2°C. The increase in O2•− emission 
with cooling likely results both from increased O2•− generation and decreased 
O2•−-scavenging capability by MnSOD. Afu, arbitrary fluorescence units. 
[Reprinted with permission from Camara et al. (71)]. 
 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Antioxidents and Redox Signaling, Vol. 11, No. 6 (June 2009): pg. 1373-1414. DOI. This article is © Mary Ann Liebert, Inc. 
and permission has been granted for this version to appear in e-Publications@Marquette. Mary Ann Liebert, Inc. does 
not grant permission for this article to be further copied/distributed or hosted elsewhere without the express permission 
from Mary Ann Liebert, Inc. 
89 
 
Fig. 16 
Temporal relation between ΔΨm (TMRM fluorescence) and ROS (DCF 
fluorescence) in a cardiac myocyte. “Trigger” ROS was induced by 
photoactivation of TMRM derivatives. Note the burst of ROS after 
photoexcitation by laser scanning caused a decrease in ΔΨm, which was 
assumed to be a result of ROS-induced MPT opening. [Reprinted with 
permission from Zorov et al. (336)]. 
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Fig. 17 
Averaged mitochondrial [Ca2+] (A), NADH (B), and DHE (O2•−) (C) in 
four groups of guinea-pig isolated hearts over time. Groups are time 
control versus 30-min global ischemia (isc) at 37°C versus 17°C. Note the 
increases in mitochondrial [Ca2+] and O2•−, while NADH decreases, during 
later ischemia. Variables were measured in the left ventricle with a trifurcated 
fiberoptic probe and differential fluorescence spectrophotometry. [Reprinted 
with permission from Riess et al. (269)]. 
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Fig. 18 
Averaged DHE (O2•−) (A) and mitochondrial [Ca2+] (B), in five groups 
of guinea-pig isolated hearts over time. Groups are 30-min global 
ischemia control and preischemia treatments with MnTBAP, 
catalase + glutathione (CG), MnTBAP + CG (MCG), and l-NAME. Note that the 
MnTBAP-treated group exhibited the largest increase in [Ca2+], whereas the 
MCG-treated group exhibited the smallest increases in [Ca2+] and O2•−. 
[Reprinted with permission from Camara et al. (70)]. 
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Fig. 19 
Averaged ETH (DHE) fluorescence (O2•−) in four groups of guinea-pig 
isolated hearts over time. Note that the increase in O2•− during brief global 
ischemia (IPC, ischemic preconditioning) was attenuated by MnTBAP and that 
MnTBAP also blocked the reduction in O2•− afforded by IPC so that O2•− 
increased to the level of the ischemia control. [Reprinted with permission 
from the publisher of Kevin et al. (181)]. 
 
  
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Antioxidents and Redox Signaling, Vol. 11, No. 6 (June 2009): pg. 1373-1414. DOI. This article is © Mary Ann Liebert, Inc. 
and permission has been granted for this version to appear in e-Publications@Marquette. Mary Ann Liebert, Inc. does 
not grant permission for this article to be further copied/distributed or hosted elsewhere without the express permission 
from Mary Ann Liebert, Inc. 
93 
 
Fig. 20 
Dependence of H2O2 production during state 3 (A) and state 4 (B) on 
[O2] in mitochondria isolated from rat liver. Note that at <5 μM [O2], 
H2O2 production decreased toward zero. Experiments were conducted in the 
presence of succinate + rotenone and oligomycin (state 4 only). [Reprinted 
with permission from Hoffman et al. (161)]. 
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Fig. 21 
Schema of glutaredoxin and thioredoxin buffering system in the 
mitochondrion. Glutathione is transported across the outer membrane (OM) 
via porin into the intermembrane space (IMS) and across the inner membrane 
(IM) via a transporter (trans) to the matrix. Other redox proteins are 
transported via the TOM and TIM23 complexes. The glutaredoxin and 
thioredoxin reactions in the matrix repair oxidatively damaged proteins. [Used 
with permission and modified from Koehler et al. (189)]. 
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Fig. 22 
Pathways of reactive O2 metabolism. O2•− and H2O2 exert protective 
effects on the cell via signaling pathways for preconditioning via 
phosphorylation products and via oxidant-induced gene products that 
activate multiple groups of proteins. Severe hypoxia, ischemia and 
reperfusion, and toxins can cause excessive oxidant stress that leads to cell-
damaging effects of ferryl radicals such as Fe(IV) = O•. [Used with permission 
and modified from Becker (27)]. 
 
  
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Antioxidents and Redox Signaling, Vol. 11, No. 6 (June 2009): pg. 1373-1414. DOI. This article is © Mary Ann Liebert, Inc. 
and permission has been granted for this version to appear in e-Publications@Marquette. Mary Ann Liebert, Inc. does 
not grant permission for this article to be further copied/distributed or hosted elsewhere without the express permission 
from Mary Ann Liebert, Inc. 
96 
 
Fig. 23 
Pathways of NO•, O2•−, and HO• and their reactive lipid products, 
including lipid peroxides (1), 15-deoxy-Δ12,14-protaglandin J2 (2), 
isoprostane J2 (3), 4-hydroxynonenal (4-HNE) (4), acrolein (5), 
nitrolinoleic acid (6), and lysoPC (7). [Used with permission and modified 
from Zmijewski et al. (334)]. 
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Fig. 24 
Correlations between mitochondrial H+ leak, metabolic rate, and 
membrane fatty acid polyunsaturation in liver mitochondria. 
[Reprinted with permission from Brookes (55)]. 
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Fig. 25 
Assessment of proton leak from the downward shift in the ΔΨm 
versus respiratory-rate curve after IPC + ischemia versus ischemia 
alone (IR); no ischemia is control (CON). Note the decrease in respiration 
after IPC compared with IR at 160 mV (insert), indicating less proton leak. 
Data from rat mitochondria isolated at 30 min of reperfusion after ischemia. 
[Reprinted with permission from Nadtochiy et al. (238)]. 
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Fig. 26 
The K+ cycle in heart mitochondria. In this model, electrophoretic matrix 
K+ influx (leak) is matched by electrogenic H+ efflux (ETS), and K+ influx via 
KATP and Kca channels is matched by K+ efflux and H+ influx via KHE (K+/H+). 
The H+ influx is accompanied by phosphate influx (Pi); a net uptake of 
phosphoric acid and salt occurs, so that matrix swelling occurs. Finally, matrix 
alkalinization releases the KHE from allosteric inhibition by protons, and its 
activity increases to match K+ influx. [Used with permission and modified 
from Costa et al. (95)]. 
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Fig. 27 
Small increases in O2•− generation assessed by DHE fluorescence 
(ETH) in isolated hearts during treatment with the anesthetic 
sevoflurane (Sevo) (A) were blocked by the SOD mimetic MnTBAP (C, 
D) but not by the KATP channel inhibitor 5-HD (B, D). [Reprinted with 
permission from Kevin et al. (182)]. 
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Fig. 28 
Proposed effect of submaximal K+ influx with mBKCa channel opening 
(1) on proton leak (2), proton ejection and respiration (3), ΔΨm (4) 
and generation of O2•-and H2O2 (5). Net effect of mBKCa channel opening 
(B) (vs. closed, A) would be to accelerate electron flux without a change in 
ΔΨm due to support by proton leak; maintained ΔΨm and higher electron flow 
would accelerate ROS generation. [Reprinted with permission from Heinen et 
al. (159)]. 
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Fig. 29 
Mitochondrial H2O2 release rate from heart isolated mitochondria. (A) 
Representative trace for 30 μM NS-1619–induced increase in cumulative H2O2 
release with succinate + rotenone as substrate. Maximal ROS production was 
stimulated in some experiments by adding complex III blocker antimycin A 
(5 μM). Catalase (300 U/ml) was added to confirm H2O2 production. Open 
arrow a, baseline; open arrow b, treatment effect. (B) Summary of H2O2 
release rates. All treatment effects are compared with baseline of the same 
experiment. [Reprinted with permission from Heinen et al. (159)]. 
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Fig. 30 
ROS production (Cbx-DCF fluorescence) in rat-heart mitochondria 
over time after adding (before time zero) valinomycin (Val), 
diazoxide (Dzy), and 5-hydroxydecanoate (5-HD) singly or together 
with ATP to maintain state 4 (A). ROS production was obtained from the 
initial slopes of traces such as those shown in (A) and plotted as percentage 
ATP-inhibited control rate obtained in the absence of drug. Adding ROS 
scavenger N-(2-mercaptopropyonyl)glycine (MPG) decreased ROS production 
in the presence of Dzy and Val ∼10-fold (B). [Reprinted with permission from 
Andrukhiv et al. (9)]. 
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Fig. 31 
Effects of BKCa channel opener NS1619 on attenuating O2•− emission 
(A) and NADH (B) during ischemia and reperfusion in guinea-pig 
isolated hearts were largely reversed by BKCa channel blocker 
paxilline (PX) or by SOD mimetic MnTBAP (TB). *p < 0.05 vs. Con, 
NS + PX, NS + TB. [Reprinted with permission from Stowe et al. (298)]. 
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Fig. 32 
Effect of reversible complex I inhibitor amobarbital on O2•− 
generation (DHE fluorescence) (A) and mitochondrial [Ca2+] (B) 
during ischemia and reperfusion in guinea-pig isolated hearts. Arrow, 
1-min amobarbital perfusion immediately before ischemia. Inset: Effect of 
amobarbital before ischemia on O2•− emission and [Ca2+]. White and hatched 
bars, baseline and 1 min of treatment, respectively. [Reprinted with 
permission from Aldakkak et al. (5)]. 
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Fig. 33 
Electrons derived from reducing equivalents are transferred through 
the respiratory system to complex IV where 4e− are transferred to O2. 
During hypoxia, this transfer is slowed, even though sufficient O2 exists to 
function as the electron acceptor. The resulting buildup of electrons and NADH 
may set up a condition for electron leak to O2, partially bypassing complex IV. 
[Used with permission of and modified from Chandel and Schumacker (80)]. 
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Fig. 34 
Effect of H2O2 on TCA cycle and products of 2-oxo acid nonenzymatic 
oxidation on metabolism (A) and signaling (B). (A) Pyruvate (PYR), α-
ketoglutarate (KGL), and oxaloacetate (OA) are decarboxylated by H2O2 to 
form acetate, succinate, and malonate (broken line) nonenzymatically instead 
of acetyl-CoA (acCoA), succinyl-CoA (sucCoA), and malate (MAL), or 
phosphoenolpyruvate (PEP) formed enzymatically (solid line) and are used to 
synthesize fatty acids, cholesterol, and glucose. ROS inhibit the TCA cycle 
mainly at aconitase and α-ketoglutarate dehydrogenase (KGDH) (thick 
arrow). The truncated Krebs cycle instead of the omitted steps of citric acid 
(citrate, CIT; cis-aconitate, cAC; isocitrate, ISC) is closed by transamination 
of OA with glutamate (GLU), which leads to formation of KGL and aspartate 
(ASP). As a part of the malate/aspartate shunt, these substrates enter the 
cytosol where OA is formed by transaminase from ASP or citrate lyase from 
citrate. (B) HIF-1α degrades in cells at normal O2 levels after prolyl residue 
hydroxylation by O2/KGL/Fe(II)-dependent hydroxylase. Hypoxia, succinate, 
and KGL decarboxylation by H2O2, which leads to decreased KGL and 
increased succinate, inhibits the enzyme, permitting transport of HIF-1α to 
the nucleus and HIF-dependent transcription of a wide variety of genes 
responsible for O2 transport, vascularization, and anaerobic energy 
production. [Used with permission of and modified from Fedotcheva et al. 
(121)]. 
 
